image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k | table_fragment_1 stringlengths 43 8.42k | table_fragment_2 stringlengths 39 8.21k |
|---|---|---|---|---|
eeaedc59a97f4cb215f7a4a3c390ec1d082df1b49531b160d004dec1453c28eb.png | simple | <table><tr><td>Outcome</td><td>Unadjusted Estimate (95% CI)</td><td>Unadjusted <i>p</i> Value</td><td>Adjusted Estimate (95% CI)</td><td>Adjusted <i>p</i> Value</td></tr><tr><td>BPD</td><td></td><td>0.507 <sup>†</sup></td><td></td><td>0.546 <sup>†</sup></td></tr><tr><td>- 28 Weeks</td><td>0.01 (−0.10,... | <table><tr><td>Outcome</td><td>Unadjusted Estimate (95% CI)</td><td>Unadjusted p Value</td><td>Adjusted Estimate (95% CI)</td><td>Adjusted p Value</td></tr><tr><td>BPD</td><td></td><td>0.507 †</td><td></td><td>0.546 †</td></tr><tr><td>- 28 Weeks</td><td>0.01 (−0.10, 0.11)</td><td>0.921</td><td>−0.01 (−0.11, 0.10)</td><... | <table><tr><td>Outcome</td><td>Unadjusted Estimate (95% CI)</td><td>Unadjusted p Value</td><td>Adjusted Estimate (95% CI)</td><td>Adjusted p Value</td></tr><tr><td>- 36 Weeks</td><td>−0.01 (−0.20, 0.10)</td><td>0.915</td><td>−0.03 (−0.22, 0.16)</td><td>0.753</td></tr><tr><td>MTLM</td><td></td><td>0.433 †</td><td></td><... |
800876e86dfcc61fefffa65f17e0cc7320fb4b24119ed7844cb8811c58ce0e70.png | complex | <table><tr><td>Cooking fuel</td><td colspan="3">Numbers of patients</td><td colspan="2">Cases vs non-eye-disease controls</td><td colspan="2">Case vs non-cataract eye-disease patients</td><td colspan="2">Case vs combined controls</td></tr><tr><td></td><td>CS</td><td>NE</td><td>NC</td><td>a-OR (95% CI)</td><td>p- value*... | <table><tr><td>Cooking fuel</td><td colspan="3">Numbers of patients</td><td colspan="2">Cases vs non-eye-disease controls</td><td colspan="2">Case vs non-cataract eye-disease patients</td><td colspan="2">Case vs combined controls</td></tr><tr><td></td><td>CS</td><td>NE</td><td>NC</td><td>a-OR (95% CI)</td><td>p- value*... | <table><tr><td>es</td><td>27</td><td></td><td>13</td><td>, 4.43)</td><td></td><td> (1.15, 6.15)</td><td></td><td> 4.26)</td><td></td></tr><tr><td>Formal education</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>At least secondary</td><td>6</td><td>17</td><td>13</td><td>... |
f36039a5af3b894a9c9a4414af9602f8a44c80f61934375d04bcac83174a91cd.png | simple | <table><tr><td>Monkey Species and ID</td><td>Protein(ng/ml)</td><td>Levels of p27 (ng/ml)</td><td>TCID50I.U./ml</td><td>Viral copy #x 10<sup>7 </sup>per ml</td></tr><tr><td>SM-FYy</td><td>784.8</td><td>119.41</td><td>2.2355</td><td>3.13</td></tr><tr><td>SM-FMy</td><td>474.6</td><td>63.03</td><td>1.1771</td><td>2.76</td... | <table><tr><td>Monkey Species and ID</td><td>Protein(ng/ml)</td><td>Levels of p27 (ng/ml)</td><td>TCID50I.U./ml</td><td>Viral copy #x 107 per ml</td></tr><tr><td>SM-FYy</td><td>784.8</td><td>119.41</td><td>2.2355</td><td>3.13</td></tr></table> | <table><tr><td>Monkey Species and ID</td><td>Protein(ng/ml)</td><td>Levels of p27 (ng/ml)</td><td>TCID50I.U./ml</td><td>Viral copy #x 107 per ml</td></tr><tr><td>SM-FMy</td><td>474.6</td><td>63.03</td><td>1.1771</td><td>2.76</td></tr><tr><td>SM-FJt</td><td>384.8</td><td>48.7</td><td>4.1347</td><td>3.83</td></tr><tr><td... |
f8ed179d053a243a6fc53f46264a61b7e85e36cf4eef684570bbf5586cb4b88d.png | simple | <table><tr><td>Cut-off</td><td>Maxillary</td><td>Anterior ethmoid</td><td>Posterior ethmoid</td><td>Frontal</td><td>Sphenoid</td></tr><tr><td>>3 mm*</td><td>26</td><td>4</td><td>4</td><td>2</td><td>3.5</td></tr><tr><td>>4 mm*</td><td>25</td><td>3</td><td>2.8</td><td>1.4</td><td>3.2</td></tr></table> | <table><tr><td>Cut-off</td><td>Maxillary</td><td>Anterior ethmoid</td><td>Posterior ethmoid</td><td>Frontal</td><td>Sphenoid</td></tr></table> | <table><tr><td>>3 mm*</td><td>26</td><td>4</td><td>4</td><td>2</td><td>3.5</td></tr><tr><td>>4 mm*</td><td>25</td><td>3</td><td>2.8</td><td>1.4</td><td>3.2</td></tr></table> |
ca4f46d83f055f1532bbcf0717215808a3c2bf7fc97d4695d3b54bcbbe46c7aa.png | complex | <table><tr><td colspan="2">Molecular function</td><td colspan="2">Biological process</td><td colspan="2">Cellular function</td></tr><tr><td>GO term</td><td>GO score</td><td>GO term</td><td>GO score</td><td>GO term</td><td>GO score</td></tr><tr><td>GO:0043169</td><td>0.96</td><td>GO:0006689</td><td>0.80</td><td>GO:00160... | <table><tr><td colspan="2">Molecular function</td><td colspan="2">Biological process</td><td colspan="2">Cellular function</td></tr><tr><td>GO term</td><td>GO score</td><td>GO term</td><td>GO score</td><td>GO term</td><td>GO score</td></tr><tr><td>GO:0043169</td><td>0.96</td><td>GO:0006689</td><td>0.80</td><td>GO:00160... | <table><tr><td>GO:0042803</td><td>0.56</td><td>GO:0019915</td><td>0.80</td></tr><tr><td></td><td></td><td>GO:0007605</td><td>0.80</td></tr><tr><td></td><td></td><td>GO:0007040</td><td>0.80</td></tr><tr><td></td><td></td><td>GO:0001501</td><td>0.80</td></tr><tr><td></td><td></td><td>GO:0008219</td><td>0.80</td></tr><tr>... |
352f172e4738b0bdc46cce510ef3762f15f5b26415908347dde06b4575950242.png | complex | <table><tr><td rowspan="2"></td><td>RMAP</td><td>Posterior PMR</td><td>Anterior PMR</td><td rowspan="2">P-value</td></tr><tr><td>(n = 23)</td><td>(n = 10)</td><td>(n = 6)</td></tr><tr><td>Age, years</td><td>70 ± 6</td><td>65 ± 7</td><td>68 ± 8</td><td>0.16</td></tr><tr><td>Male</td><td>17 (73.9)</td><td>... | <table><tr><td rowspan="2"></td><td>RMAP</td><td>Posterior PMR</td><td>Anterior PMR</td><td rowspan="2">P-value</td></tr><tr><td>(n = 23)</td><td>(n = 10)</td><td>(n = 6)</td></tr></table> | <table><tr><td>Age, years</td><td>70 ± 6</td><td>65 ± 7</td><td>68 ± 8</td><td>0.16</td></tr><tr><td>Male</td><td>17 (73.9)</td><td>9 (90.0)</td><td>3 (50.0)</td><td>0.21</td></tr><tr><td colspan="5">NYHA functional class</td></tr><tr><td>1</td><td>2 (8.7)</td><td>0</td><td>0</td><td>0.48</td></tr><tr><td>2</td><td>12 ... |
681b9b3638cbccb3c26969c0e8af2de971981a1df20b1544876b6f369322cd68.png | complex | <table><tr><td colspan="4">Center</td></tr><tr><td>Parameter</td><td>R<sup>2*</sup></td><td><i>P</i><sup>*</sup></td><td>Correlation</td></tr><tr><td> p120-catenin membrane vs. β-catenin membrane</td><td>0.15</td><td><0.01</td><td>positive</td></tr><tr><td> vs. β-catenin cytoplasm</td><td>0.07</td><td>0.03... | <table><tr><td colspan="3">Center</td></tr><tr><td>Parameter</td><td>R2*</td><td>P*</td></tr><tr><td>p120-catenin membrane vs. β-catenin membrane</td><td>0.15</td><td><0.01</td></tr><tr><td>vs. β-catenin cytoplasm</td><td>0.07</td><td>0.03</td></tr><tr><td>p120-catenin cytoplasm vs. β-catenin membrane</td><td>0.13</td>... | <table><tr><td>Center</td></tr><tr><td>Correlation</td></tr><tr><td>positive</td></tr><tr><td>inverse</td></tr><tr><td>inverse</td></tr><tr><td>positive</td></tr><tr><td>Invasive front</td></tr><tr><td>Correlation</td></tr><tr><td>positive</td></tr><tr><td>positive</td></tr><tr><td>positive</td></tr></table> |
54e0d0547d30a94a245d6b8b8b9cf91e69722f4cd86f34694e4c4cb0047ba569.png | complex | <table><tr><td></td><td colspan="4">Age and sex-adjusted</td></tr><tr><td></td><td>Beta</td><td>95% CI</td><td>p</td><td>R<sup>2</sup></td></tr><tr><td colspan="5">Vascular risk factors (VRFs)</td></tr><tr><td> Hypertension</td><td>−0.049</td><td>(−0.617, 0.519)</td><td>0.87</td><td>0.04</td></tr><tr><td> H... | <table><tr><td></td><td colspan="4">Age and sex-adjusted</td></tr><tr><td></td><td>Beta</td><td>95% CI</td><td>p</td><td>R2</td></tr><tr><td colspan="5">Vascular risk factors (VRFs)</td></tr><tr><td>Hypertension</td><td>−0.049</td><td>(−0.617, 0.519)</td><td>0.87</td><td>0.04</td></tr><tr><td>Hypercholesterolemia</td><... | <table><tr><td></td><td colspan="4">Age and sex-adjusted</td></tr><tr><td>Smoking (current)</td><td>0.050</td><td>(−0.677, 0.778)</td><td>0.89</td><td>0.04</td></tr><tr><td>≥ 2 VRFs</td><td>0.121</td><td>(−0.370, 0.612)</td><td>0.63</td><td>0.03</td></tr><tr><td>≥ 3 VRFs</td><td>−0.371</td><td>(−0.889, 0.147)</td><td>0... |
dd5cd9825cb67953f028df82656a46e023cbe4aae8b877101d5d5da0da74d5c2.png | complex | <table><tr><td rowspan="2"></td><td colspan="3">Placebo</td><td colspan="3">Coffee</td></tr><tr><td>base</td><td>30 min</td><td>60 min</td><td>base</td><td>30 min</td><td>60 min</td></tr><tr><td>HR (bpm)</td><td>68.1 <i>±</i> 13.3</td><td>64.4 <i>±</i> 13.4</td><td>66.3 <i>±</i> 15.3</td><td>73.6 <i>... | <table><tr><td></td><td colspan="3">Placebo</td><td colspan="3">Coffee</td></tr></table> | <table><tr><td></td><td>base</td><td>30 min</td><td>60 min</td><td>base</td><td>30 min</td><td>60 min</td></tr><tr><td>HR (bpm)</td><td>68.1 ± 13.3</td><td>64.4 ± 13.4</td><td>66.3 ± 15.3</td><td>73.6 ± 10.1</td><td>68.7 ± 12.4</td><td>69.4 ± 14.4</td></tr><tr><td>SBP (mmHg)</td><td>114.3 ± 5.2</td><td>117.9 ± 7.3</td>... |
86bea152e1772f3da349350573fef53ad2e7b8f517ee4ae39fde93fddae315a6.png | complex | <table><tr><td colspan="2">Type of test</td><td>G1</td><td>G2</td><td>G3</td><td>G4</td></tr><tr><td rowspan="2">LR_tests of fixed effects</td><td>Spatial fixed effects</td><td>6732.35**</td><td>2607.12**</td><td>2021.77**</td><td>415.62**</td></tr><tr><td>Temporal fixed effects</td><td>7461.23**</td><td>2729.13**</td>... | <table><tr><td colspan="2">Type of test</td><td>G1</td><td>G2</td><td>G3</td><td>G4</td></tr></table> | <table><tr><td rowspan="2">LR_tests of fixed effects</td><td>Spatial fixed effects</td><td>6732.35**</td><td>2607.12**</td><td>2021.77**</td><td>415.62**</td></tr><tr><td>Temporal fixed effects</td><td>7461.23**</td><td>2729.13**</td><td>753.29**</td><td>309.58**</td></tr><tr><td>LM_Tests</td><td>LM Lag test</td><td>15... |
70c30d51c54355e3b7c5e77a009809cba7537584e0d85349ce9b510b3512be95.png | simple | <table><tr><td> </td><td>Br</td><td>Au</td><td>In</td><td>Vi</td></tr><tr><td>Br</td><td>-</td><td>0.146</td><td>0.108</td><td>0.177</td></tr><tr><td>Au</td><td>0.216</td><td>-</td><td>0.037</td><td>0.092</td></tr><tr><td>In</td><td>0.211</td><td>0.168</td><td>-</td><td>0.052</td></tr><tr><td>Vi</td><td>0.196</td><td>0... | <table><tr><td></td><td>Br</td><td>Au</td><td>In</td><td>Vi</td></tr></table> | <table><tr><td>Br</td><td>-</td><td>0.146</td><td>0.108</td><td>0.177</td></tr><tr><td>Au</td><td>0.216</td><td>-</td><td>0.037</td><td>0.092</td></tr><tr><td>In</td><td>0.211</td><td>0.168</td><td>-</td><td>0.052</td></tr><tr><td>Vi</td><td>0.196</td><td>0.155</td><td>0.103</td><td>-</td></tr></table> |
c11cf525fc242608e0e1c694f37246f154298c022752ab0da1207733bfc6bb65.png | simple | <table><tr><td>Operation Mode</td><td>Operation Current</td><td>Power Consumption</td></tr><tr><td>Idle</td><td>2 mA</td><td>2 mAh</td></tr><tr><td>Data sampling</td><td>80 mA</td><td>0.178 mAh</td></tr><tr><td>Data transmitting</td><td>60 mA</td><td>0.067 mAh</td></tr></table> | <table><tr><td>Operation Mode</td><td>Operation Current</td></tr><tr><td>Idle</td><td>2 mA</td></tr><tr><td>Data sampling</td><td>80 mA</td></tr><tr><td>Data transmitting</td><td>60 mA</td></tr></table> | <table><tr><td>Power Consumption</td></tr><tr><td>2 mAh</td></tr><tr><td>0.178 mAh</td></tr><tr><td>0.067 mAh</td></tr></table> |
661b905a736dcff3f0d278d04641040317ac9de347f0099f36de6bfc5fefcb2b.png | simple | <table><tr><td>Categories emerged</td><td>Positive valued</td><td>Negative valued</td></tr><tr><td>The degree of difficulty/demand of the studies</td><td>The degree of difficulty/demand was experienced as stimulating</td><td>The degree of difficulty/demand was experienced as too heavy</td></tr><tr><td>The teachers enga... | <table><tr><td>Categories </td><td>Positive</td><td>Negative valu</td></tr></table> | <table><tr><td>emerged</td><td> valued</td><td>ed</td></tr><tr><td>The degree of difficulty/demand of the studies</td><td>The degree of difficulty/demand was experienced as stimulating</td><td>The degree of difficulty/demand was experienced as too heavy</td></tr><tr><td>The teachers engagement</td><td>Very engaged teac... |
a9a0b19370a7d3b424ba1984c2e4311869728787214bd09c893e980168bb936d.png | complex | <table><tr><td> </td><td colspan="3">Population</td><td colspan="2">Intervention</td><td colspan="2">Assessment tool(s)<sup>a</sup></td><td colspan="2">Analysis</td></tr><tr><td>Papers</td><td>Randomization</td><td>Justification of sample size</td><td>Control group</td><td>Allocation concealment</td><td>Underlying theo... | <table><tr><td></td><td colspan="3">Population</td><td colspan="2">Intervention</td><td colspan="2">Assessment tool(s)a</td><td colspan="2">Analysis</td></tr><tr><td>Papers</td><td>Randomization</td><td>Justification of sample size</td><td>Control group</td><td>Allocation concealment</td><td>Underlying theory</td><td>V... | <table><tr><td></td><td colspan="3">Population</td><td colspan="2">Intervention</td><td colspan="2">Assessment tool(s)a</td><td colspan="2">Analysis</td></tr><tr><td>Papers</td><td>Randomization</td><td>Justification of sample size</td><td>Control group</td><td>Allocation concealment</td><td>Underlying theory</td><td>V... |
a0b26ede6f4dc63e1964df4db654ea0261e5f3e48b261ef0475770b69a9aac95.png | complex | <table><tr><td rowspan="2">Parameter</td><td colspan="3">Youth (<i>n</i> = 618)</td><td colspan="3">Middle age (<i>n</i> = 613)</td><td colspan="3">Senior (<i>n</i> = 279)</td></tr><tr><td>Total sample</td><td>Men </td><td>Women </td><td>Total sample</td><td>Men </td><td>Women </td><td>Total sample</td><td>Men </td><td... | <table><tr><td rowspan="2">Parameter</td><td colspan="3">Youth (n = 618)</td><td colspan="3">Middle age (n = 613)</td><td colspan="3">Senior (n = 279)</td></tr><tr><td>Total sample</td><td>Men</td><td>Women</td><td>Total sample</td><td>Men</td><td>Women</td><td>Total sample</td><td>Men</td><td>Women</td></tr></table> | <table><tr><td>Age (yr)</td><td>30.8 ± 5.7</td><td>30.4 ± 5.5</td><td>31.1 ± 5.8</td><td>49.2 ± 5.5</td><td>49.2 ± 5.8</td><td>49.2 ± 5.8</td><td>68.1 ± 4.5</td><td>68.9 ± 4.2</td><td>67.5 ± 4.6</td></tr><tr><td>BMI (kg/m2)</td><td>22.5 ± 3.6</td><td>23.5 ± 3.6</td><td>21.7 ± 3.4</td><td>24.3 ± 3.3</td><td>24.5 ± 3.1</... |
85df2df029d39c9f0910572c7a6a76186443bff44cbe2003e523582aa8b1704d.png | simple | <table><tr><td>Mediator</td><td>Control</td><td>S</td><td>S+D</td><td>S+C1</td><td>S+C2</td><td>S+C3</td></tr><tr><td>Total protein</td><td>5.35±0.25</td><td>9.1±0.32</td><td>7.36±1.81</td><td>14.80±2.66</td><td>4.90±1.18</td><td>3.94±0.51</td></tr><tr><td>PLA2</td><td>7.49±0.54</td><... | <table><tr><td>Mediator</td><td>Control</td><td>S</td></tr><tr><td>Total protein</td><td>5.35±0.25</td><td>9.1±0.32</td></tr><tr><td>PLA2</td><td>7.49±0.54</td><td>12.12±1.34</td></tr><tr><td>Histamine</td><td>7.73±1.15</td><td>32.92±1.62</td></tr></table> | <table><tr><td>S+D</td><td>S+C1</td><td>S+C2</td><td>S+C3</td></tr><tr><td>7.36±1.81</td><td>14.80±2.66</td><td>4.90±1.18</td><td>3.94±0.51</td></tr><tr><td>7.68±0.75</td><td>22.05±3.07</td><td>7.48±0.09</td><td>7.39±0.04</td></tr><tr><td>28.45±2.01</td><td>27.05±1.81</td><td>17.34±2.3</td><td>1.84±0.25***</td></tr></t... |
c6af92501ff1443aeac8f5fba3996d01ac576c5df8a4088b352e6cc342003d41.png | complex | <table><tr><td> </td><td>Mean</td><td>SD</td><td>Cronbach's <i>α</i></td><td>RA</td><td>PC</td><td>EU</td><td>IUMHS</td></tr><tr><td rowspan="2">RA</td><td rowspan="2">2.37</td><td rowspan="2">0.92</td><td rowspan="2">0.90</td><td>CR = 0.93</td><td rowspan="2"> </td><td rowspan="2"> </td><td rowspan="2"> </td></tr... | <table><tr><td></td><td>Mean</td><td>SD</td><td>Cronbach's α</td><td>RA</td><td>PC</td><td>EU</td><td>IUMHS</td></tr><tr><td rowspan="2">RA</td><td rowspan="2">2.37</td><td rowspan="2">0.92</td><td rowspan="2">0.90</td><td>CR = 0.93</td><td rowspan="2"></td><td rowspan="2"></td><td rowspan="2"></td></tr><tr><td>AVE = 0... | <table><tr><td></td><td>Mean</td><td>SD</td><td>Cronbach's α</td><td>RA</td><td>PC</td><td>EU</td><td>IUMHS</td></tr><tr><td rowspan="2"></td><td rowspan="2">45</td><td rowspan="2">13</td><td rowspan="2">.81</td><td rowspan="2">3</td><td rowspan="2">9</td><td> 0.89</td><td rowspan="2"></td></tr><tr><td>AVE = 0.74</td><... |
1455d5b5941b5d9ab964630995427e14a634b353d4d00c33b9bceea9b1dd3049.png | simple | <table><tr><td>Disease</td><td>Regimen</td><td>No. pts.</td><td>PFS</td><td>Efficacy</td><td>Ref.</td></tr><tr><td>Metastatic head and neck cancer</td><td><i>Vorinostat:</i> 400 mg orally daily</td><td>13</td><td></td><td>SD 2 pts. OR 0%</td><td>[51]</td></tr><tr><td>Metastatic breast cancer</td><td><i>Vorinostat:</i> ... | <table><tr><td>Disease</td></tr><tr><td>Metastatic head and neck cancer</td></tr><tr><td>Metastatic breast cancer</td></tr><tr><td>Relapsed NSCLC</td></tr><tr><td>Metastatic prostate cancer</td></tr><tr><td>Ovarian or primary peritoneal carcinoma</td></tr><tr><td>Recurrent GBM</td></tr><tr><td>Metastatic colorectal can... | <table><tr><td>Regimen</td><td>No. pts.</td><td>PFS</td><td>Efficacy</td><td>Ref.</td></tr><tr><td>Vorinostat: 400 mg orally daily</td><td>13</td><td></td><td>SD 2 pts. OR 0%</td><td>[51]</td></tr><tr><td>Vorinostat: 400 mg orally daily</td><td>14</td><td></td><td>SD 4 pts</td><td>[52]</td></tr><tr><td>Vorinostat: 400 ... |
8f4b427de9f60fc46025f0ff65e69e834bc29c0917fe094835c2c92822deccf2.png | complex | <table><tr><td>Bacteria, plasmid, or gene</td><td>Relevant features or sequence (5′–3′)</td><td>References or sources</td></tr><tr><td colspan="3">Bacteria</td></tr><tr><td> <i>E. coli</i> DH5α</td><td>endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR F- Φ80d<i>lacZ</i>ΔM15 Δ(<i>lacZYA</i... | <table><tr><td>Bacteria, plasmid, or gene</td><td>Relevant features or sequence (5′–3′)</td><td>References or sources</td></tr><tr><td colspan="3">Bacteria</td></tr><tr><td>E. coli DH5α</td><td>endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR F- Φ80dlacZΔM15 Δ(lacZYA-argF)U169, hsdR17(rK- mK +), λ–</td><td>Invitrogen</td></t... | <table><tr><td>Bacteria, plasmid, or gene</td><td>Relevant features or sequence (5′–3′)</td><td>References or sources</td></tr><tr><td>L. lactis NZ9000</td><td>MG1363 nisRK ΔpepN</td><td>NIZO [35, 36]</td></tr><tr><td>Lb. plantarum ATCC 8014</td><td>Wild type</td><td>ATCC</td></tr><tr><td colspan="3">Plasmid</td></tr><... |
e8a0c736b0fbe9d8629352b6bd3f41c06bbfff940445f8defc3f12c209ae0106.png | complex | <table><tr><td>Predictors</td><td colspan="2">Model 8</td><td colspan="2">95% CI</td></tr><tr><td colspan="5"><i>Fixed effects</i></td></tr><tr><td> Intercept</td><td>−0.81 *</td><td>(0.35)</td><td>−1.55</td><td>−0.09</td></tr><tr><td> Ego gender</td><td>0.25</td><td>(0.51)</td><td>−0.80</td><td... | <table><tr><td>Predictors</td><td colspan="2">Model 8</td><td>95% CI</td></tr><tr><td colspan="4">Fixed effects</td></tr><tr><td>Intercept</td><td>−0.81 *</td><td>(0.35)</td><td>−1.55</td></tr><tr><td>Ego gender</td><td>0.25</td><td>(0.51)</td><td>−0.80</td></tr><tr><td>Change in activity scorea</td><td>0.38 **</td><td... | <table><tr><td>95% CI</td></tr><tr><td>Fixed effects</td></tr><tr><td>−0.09</td></tr><tr><td>1.30</td></tr><tr><td>0.59</td></tr><tr><td>−0.38</td></tr><tr><td>0.68</td></tr><tr><td>0.35</td></tr><tr><td>0.64</td></tr><tr><td>1.00</td></tr><tr><td>Covariance parameters</td></tr><tr><td>2.20</td></tr></table> |
5b54140d2ccbf939ec6b8c191681588794b949c4fd6a84a69677cb90fc0164c2.png | simple | <table><tr><td>miRNA</td><td>RT (Primer)</td><td>PCR (Forward primer)</td><td>PCR (Reverse primer)</td></tr><tr><td>mir-144</td><td>GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACCAGTACA</td><td>CGGCCGGTACAGTATAGATGA</td><td>GTGCAGGGTCCGAGGT</td></tr><tr><td>mir-106b*</td><td>GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACCG... | <table><tr><td>miRNA</td></tr><tr><td>mir-144</td></tr><tr><td>mir-106b*</td></tr><tr><td>mir-669k*</td></tr><tr><td>mir-142-3p</td></tr><tr><td>mir-223</td></tr><tr><td>mir-210</td></tr><tr><td>mir-32*</td></tr><tr><td>mir-669C</td></tr><tr><td>mir-466i-5p</td></tr><tr><td>mir-122*</td></tr><tr><td>mir-34C*</td></tr><... | <table><tr><td>RT (Primer)</td><td>PCR (Forward primer)</td><td>PCR (Reverse primer)</td></tr><tr><td>GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACCAGTACA</td><td>CGGCCGGTACAGTATAGATGA</td><td>GTGCAGGGTCCGAGGT</td></tr><tr><td>GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACCGCAGCA</td><td>AATGCCGCACTGTGGGTACT</td><td>GTGCA... |
81f4c9186cfb69a47e699fa8f07778634ef6044ae39d8b7e5af554df8bc0a839.png | simple | <table><tr><td>Quality Index items</td><td>Imamura et al. (1998)</td><td>Tillu and Gupta (1998)</td><td>Perez Millan and Foster (2001)</td></tr><tr><td>Reporting</td><td></td><td></td><td></td></tr><tr><td>1. Study hypothesis/aim/objective</td><td>1</td><td>1</td><td>1</td></tr><tr><td>2. Main outcomes</td><td>1</td><t... | <table><tr><td>Quality Index items</td><td>Imamura et al. (1998)</td><td>Tillu and Gupta (1998)</td><td>Perez Millan and Foster (2001)</td></tr><tr><td>Reporting</td><td></td><td></td><td></td></tr><tr><td>1. Study hypothesis/aim/objective</td><td>1</td><td>1</td><td>1</td></tr><tr><td>2. Main outcomes</td><td>1</td><t... | <table><tr><td>12. Were subjects who were prepared to participate representative of the entire population from which they were recruited?</td><td>0</td><td>0</td><td>0</td></tr><tr><td>13. Were the staff, places, and facilities representative of the treatment the majority of subjects received?</td><td>1</td><td>0</td><... |
270e9062448627d6b70a87eae60424d339d349ad52d772a608c6ef40bf49e204.png | simple | <table><tr><td>Paraclinical findings</td><td>Number <sup>a</sup>(%)</td><td>Number <sup>b</sup> (%)</td></tr><tr><td>Chest X ray</td><td></td><td></td></tr><tr><td>Normal</td><td>98 (94,2)</td><td>57 (96,6)</td></tr><tr><td>Abnormal</td><td>6 (5,8)</td><td>3 (5,1)</td></tr><tr><td>Cardiomegaly</td><td>2 (1,9)</td><td>1... | <table><tr><td>Paraclinical findings</td><td>Number a(%)</td><td>Number b (%)</td></tr><tr><td>Chest X ray</td><td></td><td></td></tr><tr><td>Normal</td><td>98 (94,2)</td><td>57 (96,6)</td></tr><tr><td>Abnormal</td><td>6 (5,8)</td><td>3 (5,1)</td></tr><tr><td>Cardiomegaly</td><td>2 (1,9)</td><td>1 (1,7)</td></tr><tr><t... | <table><tr><td>Paraclinical findings</td><td>Number a(%)</td><td>Number b (%)</td></tr><tr><td>Right atrial hypertrophy</td><td>10 (9,6)</td><td>4 (6,8)</td></tr><tr><td>Arrhythmia</td><td>2 (1,9)</td><td>1 (1,7)</td></tr></table> |
f264aae8790a95279eacb32dcab0bc719e51a0910718308adb528a728cf083dc.png | complex | <table><tr><td rowspan="2">PANTHER Pathways</td><td rowspan="2">Annotated</td><td colspan="4">Dapulian (DT_DC)</td><td colspan="4">Landrace (LT_LC)</td></tr><tr><td>Significant</td><td>Expected</td><td>Fold Enrichment</td><td><i>p</i>-Value</td><td>Significant</td><td>Expected</td><td>Fold Enrichment</td><td><i>p</i>-V... | <table><tr><td rowspan="2">PANTHER Pathways</td><td rowspan="2">Annotated</td><td colspan="4">Dapulian (DT_DC)</td><td colspan="4">Landrace (LT_LC)</td></tr><tr><td>Significant</td><td>Expected</td><td>Fold Enrichment</td><td>p-Value</td><td>Significant</td><td>Expected</td><td>Fold Enrichment</td><td>p-Value</td></tr>... | <table><tr><td>Ubiquitin proteasome pathway (P00060)</td><td>65</td><td>11</td><td>5.91</td><td>1.86</td><td>3.89 × 10−2</td><td>13</td><td>6.44</td><td>2.02</td><td>1.48 × 10−2</td></tr><tr><td>Gonadotropin releasing hormone receptor pathway (P06664)</td><td>223</td><td>41</td><td>20.28</td><td>2.02</td><td>3.09 × 10−... |
f651d356110361baf4d819bc9a1d1c9acc82a11c0790b60b00e7aded52a1cc11.png | complex | <table><tr><td colspan="2">Diagnosis</td></tr><tr><td>Guillain-Barré syndrome, n (%)</td><td>26 (63.4)</td></tr><tr><td>Autoimmune encephalitis, n (%)</td><td>6 (14.6)</td></tr><tr><td>Miller-Fisher syndrome, n (%)</td><td>2 (4.9)</td></tr><tr><td>Chronic relapsing inflammatory optic neuropathy (CRION), n (%)</td... | <table><tr><td colspan="2">Diagnosis</td></tr><tr><td>Guillain-Barré syndrome, n (%)</td><td>26 (63.4)</td></tr><tr><td>Autoimmune encephalitis, n (%)</td><td>6 (14.6)</td></tr></table> | <table><tr><td>Miller-Fisher syndrome, n (%)</td><td>2 (4.9)</td></tr><tr><td>Chronic relapsing inflammatory optic neuropathy (CRION), n (%)</td><td>1 (2.4)</td></tr><tr><td>Multiple sclerosis, n (%)</td><td>1 (2.4)</td></tr><tr><td>Parainfectious myelitis, n (%)</td><td>1 (2.4)</td></tr><tr><td>Myasthenia gravis, n (%... |
8b80577db167aa6bcca43dfbeec45cd34a16f9a7c688580ab2e081cc42fe1032.png | simple | <table><tr><td>Variables</td><td>Algorithm</td></tr><tr><td>P(X) = base rate of event for person X</td><td>Produce a time series for C and S events:</td></tr><tr><td>P(X|Y) = rate of event for X given Y did</td><td></td></tr><tr><td>P(X|X) = probability of event repetition</td><td>Do 1000 timesIf rand < P(C)C output... | <table><tr><td>Variables</td><td>Algorithm</td></tr><tr><td>P(X) = base rate of event for person X</td><td>Produce a time series for C and S events:</td></tr></table> | <table><tr><td>P(X|Y) = rate of event for X given Y did</td><td></td></tr><tr><td>P(X|X) = probability of event repetition</td><td>Do 1000 timesIf rand < P(C)C outputs event (=1)Else if rand < P(C|C) and C = 1C outputs eventOtherwiseC outputs no event (=0)If rand < P(S|C) and C = 1S outputs event (=1)Else if rand < P(S... |
dd8ba999bea83867d1033b5532e65cca641153c377aaa2118c76771e5d62e088.png | complex | <table><tr><td></td><td>Disability screening but not in regression model</td><td>In regression model</td><td>p Value</td><td>Number of missing values/4219 (%)</td></tr><tr><td>Allocation to intervention in original trial</td><td>316/901 (35%)</td><td>1786/3318 (54%)</td><td><0.001</td><td rowspan="4"></td></tr><tr><... | <table><tr><td></td><td>Disability screening but not in regression model</td><td>In regression model</td><td>p Value</td><td>Number of missing values/4219 (%)</td></tr><tr><td>Allocation to intervention in original trial</td><td>316/901 (35%)</td><td>1786/3318 (54%)</td><td><0.001</td><td rowspan="3"></td></tr><tr><td>... | <table><tr><td></td><td>Disability screening but not in regression model</td><td>In regression model</td><td>p Value</td><td>Number of missing values/4219 (%)</td></tr><tr><td>ce score: most expensive assets</td><td>01 (6%)</td><td>/3318 (6%)</td><td></td><td rowspan="2"></td></tr><tr><td>Positive disability screen</td... |
42bffe36394f38aaa0a49f1caa549740fe5dc41752cabf5e8e534a70ba6cb041.png | simple | <table><tr><td>Target</td><td>Active compounds</td><td>Inactive compounds</td><td>Ratio (active/inactive compounds)</td><td>Sensitivity</td><td>Precision</td><td>Specificity</td><td>κ</td></tr><tr><td>PPARA</td><td>1955</td><td>1465</td><td>1.33</td><td>0.96</td><td>0.94</td><td>0.92</td><td>0.89</td></tr><tr><td>... | <table><tr><td>Target</td><td>Active compounds</td><td>Inactive compounds</td><td>Ratio (active/inactive compounds)</td><td>Sensitivity</td><td>Precision</td><td>Specificity</td><td>κ</td></tr><tr><td>PPARA</td><td>1955</td><td>1465</td><td>1.33</td><td>0.96</td><td>0.94</td><td>0.92</td><td>0.89</td></tr><tr><td>MMP2<... | <table><tr><td>D2</td><td>13</td><td>43,076</td><td>01</td><td>6</td><td>.93</td><td>00</td><td>.94</td></tr><tr><td>GSK3B</td><td>3334</td><td>300,186</td><td>0.01</td><td>0.85</td><td>0.72</td><td>1.00</td><td>0.78</td></tr><tr><td>JAK2</td><td>2158</td><td>213,915</td><td>0.01</td><td>0.85</td><td>0.81</td><td>1.00<... |
3c4356618f329d537c601cae15a87d2103b4f2923a7609219ee5f6af864f3d78.png | complex | <table><tr><td>Prediction set</td><td>Published [14]</td><td>BRAKER1/soft-masked</td></tr><tr><td>Number of protein coding genes predicted</td><td>20,964</td><td>15,747</td></tr><tr><td>Mean protein length (amino acids)</td><td>218.8</td><td>344.5</td></tr><tr><td>Number of single exon genes</td><td>1,728</td><td>2,326... | <table><tr><td>Prediction set</td><td>Published [14]</td><td>BRAKER1/soft-masked</td></tr><tr><td>Number of protein coding genes predicted</td><td>20,964</td><td>15,747</td></tr><tr><td>Mean protein length (amino acids)</td><td>218.8</td><td>344.5</td></tr><tr><td>Number of single exon genes</td><td>1,728</td><td>2,326... | <table><tr><td>Prediction set</td><td>Published [14]</td><td>BRAKER1/soft-masked</td></tr><tr><td colspan="3">Conserved, single-copy orthologuesb</td></tr><tr><td>Total</td><td>2,089</td><td>2,330</td></tr><tr><td>Missing</td><td>377</td><td>141</td></tr><tr><td>Expanded</td><td>184</td><td>84</td></tr></table> |
b578e2102183ba1d6e70b2573940749a25475b0d5aa145241f48445d14c8b369.png | simple | <table><tr><td>Factors</td><td><i>B</i></td><td>SE</td><td>Df</td><td>Sig.</td><td>Exp ( <i>B </i>)</td><td>95% confidence interval lower/upper</td></tr><tr><td>Sex</td><td>−0.795</td><td>0.857</td><td>1</td><td>0.354</td><td>0.452</td><td>0.084/2.423</td></tr><tr><td>Age</td><td>0.135</td><td>0.061</td><td>1</td... | <table><tr><td>Factors</td><td>B</td><td>SE</td><td>Df</td><td>Sig.</td><td>Exp ( B )</td><td>95% confidence interval lower/upper</td></tr><tr><td>Sex</td><td>−0.795</td><td>0.857</td><td>1</td><td>0.354</td><td>0.452</td><td>0.084/2.423</td></tr><tr><td>Age</td><td>0.135</td><td>0.061</td><td>1</td><td>0.026</td><td>1... | <table><tr><td>FEV1 (%)</td><td>0.018</td><td>0.026</td><td>1</td><td>0.490</td><td>1.018</td><td>0.968/1.070</td></tr><tr><td>Tumour side</td><td>0.014</td><td>0.597</td><td>1</td><td>0.982</td><td>1.014</td><td>0.314/3.268</td></tr><tr><td>pT*</td><td>1.390</td><td>0.424</td><td>1</td><td>0.001</td><td>4.014</td><td>... |
4a74271fe8a62a2b15ba6e649df2b52089f1aa4d8dafb0a70a62a7184d56a9a1.png | simple | <table><tr><td>Organism</td><td>Group</td><td>tag</td><td>Lanes in Figure 2</td></tr><tr><td><i>Gallus gallus</i></td><td>Animals</td><td>CACTCACAAGCTCGACGTACAC</td><td>1 and 8</td></tr><tr><td><i>Canis familiaris</i></td><td>Animals</td><td>CAGACAGCACTCGTTCGTACAC</td><td>2 and 9</td></tr><tr><td><i>Arabidopsis thalian... | <table><tr><td>Organism</td><td>Group</td><td>tag</td><td>Lanes in Figure 2</td></tr></table> | <table><tr><td>Gallus gallus</td><td>Animals</td><td>CACTCACAAGCTCGACGTACAC</td><td>1 and 8</td></tr><tr><td>Canis familiaris</td><td>Animals</td><td>CAGACAGCACTCGTTCGTACAC</td><td>2 and 9</td></tr><tr><td>Arabidopsis thaliana</td><td>Plants</td><td>GACTGAACGTGCTCTGCTACTG</td><td>3 and 10</td></tr><tr><td>Sulfolobus ac... |
e3c70c4c9c0ab48127a95f4c58aea08cdf30c5de3a290b086af6808a485c5b1d.png | complex | <table><tr><td rowspan="3"></td><td colspan="2">Odds Ratio (95% Confidence Interval)</td></tr><tr><td colspan="2">Any pneumococcal serotype</td></tr><tr><td><i>Univariable</i></td><td><i>Multivariable</i></td></tr><tr><td>Male</td><td><i>1.56 (1.35</i>–<i>1.81)</i></td><td>0.81 (0.67–0.99)</td></tr><tr><td ... | <table><tr><td rowspan="3"></td><td colspan="2">Odds Ratio (95% Confidence Interval)</td></tr><tr><td colspan="2">Any pneumococcal serotype</td></tr><tr><td>Univariable</td><td>Multivariable</td></tr><tr><td>Male</td><td>1.56 (1.35–1.81)</td><td>0.81 (0.67–0.99)</td></tr><tr><td colspan="3">Age increase by 12 months</t... | <table><tr><td rowspan="3"></td><td colspan="2">Odds Ratio (95% Confidence Interval)</td></tr><tr><td colspan="2">Any pneumococcal serotype</td></tr><tr><td>Univariable</td><td>Multivariable</td></tr><tr><td colspan="3">Remoteness</td></tr><tr><td>Metropolitan</td><td>Ref</td><td>Ref</td></tr><tr><td>Regional</td><td>1... |
6e4e7848c07eb51819c9134d9ff25de079b274d467141912f10ebb441632b4b3.png | complex | <table><tr><td>Parameter</td><td colspan="3">Responders (n = 15)</td><td colspan="3">Nonresponders (n = 13)</td></tr><tr><td></td><td>Baseline</td><td>Before INO</td><td><i>P </i>value</td><td>Baseline</td><td>Before INO</td><td><i>P </i>value</td></tr><tr><td>Leucocytes (10<sup>6</sup>/ml)</td><td>10.4 ± 4.4</td>... | <table><tr><td>Parameter</td><td colspan="3">Responders (n = 15)</td><td colspan="3">Nonresponders (n = 13)</td></tr><tr><td></td><td>Baseline</td><td>Before INO</td><td>P value</td><td>Baseline</td><td>Before INO</td><td>P value</td></tr><tr><td>Leucocytes (106/ml)</td><td>10.4 ± 4.4</td><td>1.6 ± 1.0†</td><td>≤ 0.01<... | <table><tr><td>Parameter</td><td colspan="3">Responders (n = 15)</td><td colspan="3">Nonresponders (n = 13)</td></tr><tr><td></td><td>Baseline</td><td>Before INO</td><td>P value</td><td>Baseline</td><td>Before INO</td><td>P value</td></tr><tr><td>Proteins (mg/ml)</td><td>47 ± 6.0</td><td>33 ± 5.4†</td><td>≤ 0.01</td><t... |
4802dd782ee295a7c8ec86bc1f3e4b8bd0dfde785ea9bf05a720230b974a234c.png | simple | <table><tr><td>Breast Clinicopathological details</td><td>Cancer</td><td>Fibroadenoma</td><td>Normal</td></tr><tr><td>Number of patients</td><td>103</td><td>35</td><td>30</td></tr><tr><td>Median Patient Age yrs</td><td>56 (35-90)</td><td>44 (17-62)</td><td>46.5 (24-58)</td></tr><tr><td>Menopausal Status</td><td></td><t... | <table><tr><td>Breast Clinicopathological details</td><td>Cancer</td><td>Fibroadenoma</td><td>Normal</td></tr><tr><td>Number of patients</td><td>103</td><td>35</td><td>30</td></tr><tr><td>Median Patient Age yrs</td><td>56 (35-90)</td><td>44 (17-62)</td><td>46.5 (24-58)</td></tr><tr><td>Menopausal Status</td><td></td><t... | <table><tr><td>Luminal B (ER/PR+, HER2/neu+)</td><td>18</td></tr><tr><td>HER2 Over expressing (ER-, PR-, HER2/neu+)</td><td>16</td></tr><tr><td>Triple-Negative (ER-, PR-, HER2/neu-)</td><td>16</td></tr><tr><td>Unknown</td><td>11</td></tr><tr><td>Tumour Grade</td><td></td></tr><tr><td>1</td><td>5</td></tr><tr><td>2</td>... |
714a81da5b0bbb63079b1a6f5773bb379729518134a6cb28a39f8e5947cb531c.png | complex | <table><tr><td></td><td colspan="2">Estrogen</td><td colspan="2">Progesterone</td><td colspan="3">Her-2</td></tr><tr><td>Polymorphisms</td><td>Negative</td><td>Positive</td><td>Negative</td><td>Positive</td><td>Negative</td><td>Positive</td><td>Inconclusive</td></tr><tr><td>rs3803662 - TT N (%)</td><td>13 (16.5)</td><t... | <table><tr><td></td><td colspan="2">Estrogen</td><td colspan="2">Progesterone</td><td colspan="3">Her-2</td></tr></table> | <table><tr><td>Polymorphisms</td><td>Negative</td><td>Positive</td><td>Negative</td><td>Positive</td><td>Negative</td><td>Positive</td><td>Inconclusive</td></tr><tr><td>rs3803662 - TT N (%)</td><td>13 (16.5)</td><td>20 (18.0)</td><td>16 (18.0)</td><td>17 (16.5)</td><td>23 (16.9)</td><td>7 (14.9)</td><td>3 (100.0)</td><... |
c4124da5a7eaa654384f22034e94a8e7d1b14ae6e1be48ca242c720c29c3ec23.png | complex | <table><tr><td></td><td>Participants from wards with high staff morale<sup>a</sup> (<i>n</i> = 12)</td><td>Participants from wards with low staff morale<sup>a</sup> (<i>n</i> = 9)</td></tr><tr><td>Gender</td><td>50 % (6/12) male; 50 % (6/12) female</td><td>89 % (8/9) male; 11 % (1/9) female</td></tr><tr><td rowspan="6"... | <table><tr><td></td><td>Participants from wards with high staff moralea (n = 12)</td><td>Participants from wards with low staff moralea (n = 9)</td></tr></table> | <table><tr><td>Gender</td><td>50 % (6/12) male; 50 % (6/12) female</td><td>89 % (8/9) male; 11 % (1/9) female</td></tr><tr><td rowspan="6">Age</td><td>25 % (3/12) 16–17 years</td><td>22 % (2/9) 18–25 years</td></tr><tr><td>8 % (1/12) 18–25 years</td><td>33 % (3/9) 26–35 years</td></tr><tr><td>25 % (3/12) 26–35 years</t... |
91d1bd63e449ae062debf869477c2d602fc38c29af21be43cb4e8b08b82d4e25.png | simple | <table><tr><td>Parameter</td><td></td><td>BSP</td><td>Control</td><td>P</td></tr><tr><td>Gender</td><td>Male</td><td>62</td><td>65</td><td>>0.05</td></tr><tr><td></td><td>Female</td><td>38</td><td>35</td><td></td></tr><tr><td>Age</td><td>≤40</td><td>33</td><td>29</td><td>>0.05</td></tr><tr><td></td><td>>... | <table><tr><td>Parameter</td><td></td><td>BSP</td><td>Control</td><td>P</td></tr></table> | <table><tr><td>Gender</td><td>Male</td><td>62</td><td>65</td><td>>0.05</td></tr><tr><td></td><td>Female</td><td>38</td><td>35</td><td></td></tr><tr><td>Age</td><td>≤40</td><td>33</td><td>29</td><td>>0.05</td></tr><tr><td></td><td>>41</td><td>67</td><td>71</td><td></td></tr><tr><td>Etiology</td><td>Trauma</td><td>31</td... |
f127cf2a4d605c176cd8f51da4d7df70d605c9738f9cccfa7015c927fbf2e09c.png | complex | <table><tr><td rowspan="2"></td><td colspan="3">Group 1 (<i>n</i> = 33) admitted to HSS</td><td colspan="3">Group 2 (<i>n</i> = 27) admitted to RS</td><td rowspan="2">P value<sup>a)</sup></td></tr><tr><td>Total number</td><td>Mean per patient</td><td>SD</td><td>Total number</td><td>Mean per patient</td><td>SD</td></tr>... | <table><tr><td rowspan="2"></td><td colspan="3">Group 1 (n = 33) admitted to HSS</td><td colspan="3">Group 2 (n = 27) admitted to RS</td><td rowspan="2">P valuea)</td></tr><tr><td>Total number</td><td>Mean per patient</td><td>SD</td><td>Total number</td><td>Mean per patient</td><td>SD</td></tr><tr><td>Specialist health... | <table><tr><td>Number in-patient days at RS</td><td>117</td><td>3.5</td><td>6.4</td><td>131</td><td>4.9</td><td>11.4</td><td>0.813</td></tr><tr><td>Number in-patient days other hospitals</td><td>10</td><td>0.3</td><td>1.0</td><td>13</td><td>0.5</td><td>1.5</td><td>0.952</td></tr><tr><td>Out-patient/X-ray consult. (tota... |
7fd16486a970d53c970f8fdee976056c0f18f4db8662f53230cd1be9d887ba9f.png | simple | <table><tr><td></td><td>Cod</td><td>Whey</td><td>Gluten</td><td>Casein</td></tr><tr><td>MCP-1</td><td></td><td></td><td></td><td></td></tr><tr><td> Fasting</td><td>22 ± 11</td><td>21 ± 7</td><td>23 ± 12</td><td>21 ± 11</td></tr><tr><td> iAUC 0-240 min (pg/ml·240 min)</td><td>- 826 ± 1255x<... | <table><tr><td></td><td>Cod</td><td>Whey</td><td>Gluten</td><td>Casein</td></tr><tr><td>MCP-1</td><td></td><td></td><td></td><td></td></tr><tr><td>Fasting</td><td>22 ± 11</td><td>21 ± 7</td><td>23 ± 12</td><td>21 ± 11</td></tr><tr><td>iAUC 0-240 min (pg/ml·240 min)</td><td>- 826 ± 1255x</td><td>- 77 ± 1092y</td><td>-94... | <table><tr><td>MIP-1b</td><td></td><td></td><td></td><td></td></tr><tr><td>Fasting</td><td>45 ± 16</td><td>46 ± 16</td><td>44 ± 14</td><td>43 ± 15</td></tr><tr><td>iAUC 0-240 min (pg/ml·240 min)</td><td>-908 ± 1 248</td><td>-331 ± 1 411</td><td>-302 ± 534</td><td>-219 ± 428</td></tr><tr><td>VEGF</td><td></td><td></td><... |
8bd40974738a083eb5e494a51a618a3ccd4364fd32225f1f9ee85f3e6ee3f9b1.png | complex | <table><tr><td>Stage</td><td>Serum creatinine criteria</td></tr><tr><td rowspan="3">1</td><td>1.5-1.9 times baseline</td></tr><tr><td>OR</td></tr><tr><td>≥ 26.5 5 μmol/l (0.3 mg/dl) increase within 48 hours<sup>a</sup></td></tr><tr><td>2</td><td>2.0-2.9 times baseline</td></tr><tr><td rowspan="5">3</td><td>&... | <table><tr><td>Stage</td></tr><tr><td rowspan="3">1</td></tr><tr></tr><tr></tr><tr><td>2</td></tr><tr><td rowspan="5">3</td></tr><tr></tr><tr></tr><tr></tr><tr></tr></table> | <table><tr><td>Serum creatinine criteria</td></tr><tr><td>1.5-1.9 times baseline</td></tr><tr><td>OR</td></tr><tr><td>≥ 26.5 5 μmol/l (0.3 mg/dl) increase within 48 hoursa</td></tr><tr><td>2.0-2.9 times baseline</td></tr><tr><td>≥ 3.0 times baseline</td></tr><tr><td>OR</td></tr><tr><td>Increase in serum creatinine to ≥... |
b80c61be61abec1a4d11eab173ca0625bd9c2beb223d075a24d20093bf706801.png | simple | <table><tr><td>DMFT component</td><td>Disabledmean ± SD</td><td>Normalmean ± SD</td><td>t-value</td><td>df</td><td>P value</td></tr><tr><td>Decayed (D)</td><td>0.64 ± 1.32</td><td>1.06 ± 1.40</td><td>2.33</td><td>234</td><td>0.02</td></tr><tr><td>Missing (M)</td><td>0.68 ± 2.23</td><td>0.03 ... | <table><tr><td>DMFT component</td><td>Disabledmean ± SD</td><td>Normalmean ± SD</td><td>t-value</td><td>df</td><td>P value</td></tr><tr><td>Deca</td><td>0.64 ± 1.32</td><td>1.06</td><td>2.</td><td>234</td><td>0.0</td></tr></table> | <table><tr><td>yed (D)</td><td></td><td> ± 1.40</td><td>33</td><td></td><td>2</td></tr><tr><td>Missing (M)</td><td>0.68 ± 2.23</td><td>0.03 ± 0.21</td><td>3.2</td><td>234</td><td>0.002</td></tr><tr><td>Filled (F)</td><td>0.14 ± 0.72</td><td>0</td><td>2.1</td><td>234</td><td>0.037</td></tr><tr><td>Decayed (d)</td><td>0.... |
b1c8acee1ce9b449fc99501095ab083b210331a8ca8a7d6480dd98b15b873cda.png | complex | <table><tr><td>Characteristic</td><td colspan="2">VA</td><td colspan="2">FFS</td></tr><tr><td></td><td>OR (95% CI)</td><td>p-value</td><td>OR (95% CI)</td><td>p-value</td></tr><tr><td>Comorbidity</td><td></td><td></td><td></td><td></td></tr><tr><td> Unadjusted</td><td>0.78 (0.61, 1.00)</td><td>0.04</td><td>1.08 (0.82, ... | <table><tr><td>Characteristic</td><td colspan="2">VA</td><td colspan="2">FFS</td></tr></table> | <table><tr><td></td><td>OR (95% CI)</td><td>p-value</td><td>OR (95% CI)</td><td>p-value</td></tr><tr><td>Comorbidity</td><td></td><td></td><td></td><td></td></tr><tr><td>Unadjusted</td><td>0.78 (0.61, 1.00)</td><td>0.04</td><td>1.08 (0.82, 1.42)</td><td>0.59</td></tr><tr><td>Adjusted</td><td>0.76 (0.58, 1.00)</td><td>0... |
450dbb0141c2577e76d62c8d4c04141c2fbc911960b3296bcec373712514997b.png | simple | <table><tr><td>Factors</td><td>Categories</td><td>No. of patients (%)</td><td><i>P </i>value</td></tr><tr><td>Gender</td><td>Female</td><td>465(27.1)</td><td>0.301</td></tr><tr><td></td><td>Male</td><td>1250(72.9)</td><td></td></tr><tr><td>age</td><td></td><td>57.5 ± 10.9</td><td><0.001</td></tr><tr><td>Past me... | <table><tr><td>Factors</td><td>Categories</td><td>No. of patients (%)</td><td>P value</td></tr><tr><td>Gender</td><td>Female</td><td>465(27.1)</td><td>0.301</td></tr><tr><td></td><td>Male</td><td>1250(72.9)</td><td></td></tr><tr><td>age</td><td></td><td>57.5 ± 10.9</td><td><0.001</td></tr><tr><td>Past medical history</... | <table><tr><td>Factors</td><td>Categories</td><td>No. of patients (%)</td><td>P value</td></tr><tr><td></td><td>Upper third</td><td>193(11.3)</td><td></td></tr><tr><td></td><td>Whole stomach</td><td>155(9.03)</td><td></td></tr><tr><td>Eradicative degree of surgery</td><td>Utterly</td><td>809(47.8)</td><td><0.001</td></... |
aa3e81c5a0d4c1b60d8ec9188c4e3d05e4fa42e96306a106569affbbe02dafcb.png | simple | <table><tr><td>Method</td><td>Algorithm</td><td>False positive rate</td><td>False negative rate</td></tr><tr><td>MEMSAT-SVM</td><td>SVM</td><td>0.00%</td><td>0.44%</td></tr><tr><td>MEMSAT3</td><td>NN</td><td>0.50%</td><td>0.50%</td></tr><tr><td>SOSUI</td><td>Hydrophobicity analysis</td><td>0.33%</td><td>1.10%</td></tr>... | <table><tr><td>Method</td><td>Algorithm</td><td>False positive rate</td><td>False negative rate</td></tr><tr><td>MEMSAT-SVM</td><td>SVM</td><td>0.00%</td><td>0.44%</td></tr><tr><td>MEMSAT3</td><td>NN</td><td>0.50%</td><td>0.50%</td></tr><tr><td>SOSUI</td><td>Hydrophobicity analysis</td><td>0.33%</td><td>1.10%</td></tr>... | <table><tr><td>PHOBIUS</td><td>HMM</td><td>2.72%</td><td>0.44%</td></tr></table> |
2780f5d604981f488afdda9e02c7338ffbe5e7b693d613f0c0f31520f4585ae1.png | complex | <table><tr><td></td><td>Denmark</td><td>Norway</td><td>Sweden</td></tr><tr><td colspan="4">TKA</td></tr><tr><td> Mean</td><td>146</td><td>70</td><td>143</td></tr><tr><td> Median</td><td>132</td><td>53</td><td>105</td></tr><tr><td> Range</td><td>1–345</td><td>1–275</td><td>1–527</td></tr><tr><td colspa... | <table><tr><td></td></tr><tr><td>TKA</td></tr><tr><td>Mean</td></tr><tr><td>Median</td></tr><tr><td>Range</td></tr><tr><td>UKA</td></tr><tr><td>Mean</td></tr><tr><td>Median</td></tr><tr><td>Range</td></tr></table> | <table><tr><td>Denmark</td><td>Norway</td><td>Sweden</td></tr><tr><td colspan="3">TKA</td></tr><tr><td>146</td><td>70</td><td>143</td></tr><tr><td>132</td><td>53</td><td>105</td></tr><tr><td>1–345</td><td>1–275</td><td>1–527</td></tr><tr><td colspan="3">UKA</td></tr><tr><td>35</td><td>19</td><td>30</td></tr><tr><td>29<... |
92bd6d6a4228ff7b2225682ad865e3bd64c503a736e57432be3353cfa1cde5b6.png | complex | <table><tr><td>Genotypes</td><td>Azoospermic men (n=108)</td><td>Controls (n=119)</td><td>p-value</td><td>OR (CI; 95%)</td></tr><tr><td>AA</td><td>19 (17.6)</td><td>51 (42.8)</td><td colspan="2"></td></tr><tr><td>AG</td><td>52 (48.2)</td><td>22 (38.7)</td><td>0.149</td><td>1.47 (0.869-2.498)</td></tr><tr><td>GG</td><td... | <table><tr><td>Genotypes</td></tr><tr><td>AA</td></tr><tr><td>AG</td></tr><tr><td>GG</td></tr></table> | <table><tr><td>Azoospermic men (n=108)</td><td>Controls (n=119)</td><td>p-value</td><td>OR (CI; 95%)</td></tr><tr><td>19 (17.6)</td><td>51 (42.8)</td><td colspan="2"></td></tr><tr><td>52 (48.2)</td><td>22 (38.7)</td><td>0.149</td><td>1.47 (0.869-2.498)</td></tr><tr><td>37 (34.3)</td><td>46 (18.5)</td><td>0.007</td><td>... |
140c48cb5ae7072c24a13b47e631c15c01bbf8de17faa9edd0fc2a4d67d893f6.png | complex | <table><tr><td rowspan="2">Variable</td><td colspan="2">Univariate analysis</td><td colspan="2">Multivariate analysis</td></tr><tr><td>HR (95% CI)</td><td>p-value</td><td>HR (95% CI)</td><td>p-value</td></tr><tr><td> Age (Years)</td><td>1.04 (0.98-1.11)</td><td>0.23</td><td>1.02 (0.95-1.09)</td><td>0.68</td></tr><tr><t... | <table><tr><td rowspan="2">Variable</td><td colspan="2">Univariate analysis</td><td colspan="2">Multivariate analysis</td></tr><tr><td>HR (95% CI)</td><td>p-value</td><td>HR (95% CI)</td><td>p-value</td></tr><tr><td>Age (Years)</td><td>1.04 (0.98-1.11)</td><td>0.23</td><td>1.02 (0.95-1.09)</td><td>0.68</td></tr><tr><td... | <table><tr><td rowspan="2">Variable</td><td colspan="2">Univariate analysis</td><td colspan="2">Multivariate analysis</td></tr><tr><td>HR (95% CI)</td><td>p-value</td><td>HR (95% CI)</td><td>p-value</td></tr><tr><td>7</td><td>eference</td><td>01</td><td>e</td><td>02</td></tr><tr><td>7</td><td>2.97(1.52-5.82)</td><td>0.... |
8bddc5a825b4463d8c634a16c4619fc1483f4d1a89a46489f2a351a1a9b54ec9.png | complex | <table><tr><td>Parameter</td><td>HR</td><td>95 % CI</td><td><i>P</i></td></tr><tr><td colspan="4">Disease-free survival: Cox regression model</td></tr><tr><td>TNM stage</td><td></td><td></td><td>0.06</td></tr><tr><td> III-IV (vs. I-II)</td><td>2.528</td><td>1.299–4.921</td><td></td></tr><tr><td>Tumor differentiat... | <table><tr><td>Parameter</td><td>HR</td><td>95 % CI</td><td>P</td></tr><tr><td colspan="4">Disease-free survival: Cox regression model</td></tr><tr><td>TNM stage</td><td></td><td></td><td>0.06</td></tr><tr><td>III-IV (vs. I-II)</td><td>2.528</td><td>1.299–4.921</td><td></td></tr><tr><td>Tumor differentiation</td><td></... | <table><tr><td>Lymph node metastasis</td><td></td><td></td><td>0.417</td></tr><tr><td>Yes (vs. No)</td><td>1.233</td><td>0.743–2.048</td><td></td></tr><tr><td>AREG expression</td><td></td><td></td><td>0.03</td></tr><tr><td>Positive (vs. Negative)</td><td>1.822</td><td>1.058–3.137</td><td></td></tr></table> |
392584e510b2dd6233e0e2916959cebcf01b3fa32234e257b0942cba9b031c8b.png | simple | <table><tr><td>Comparison</td><td>CTCs</td><td>ctDNA</td><td>Exosomes</td></tr><tr><td>Origin</td><td>Includes apoptotic tumor and viable tumor cells from a primary or metastatic tumor [71, 73].</td><td>Includes cfDNA, from the viable tumor cells or from CTCs [17, 219, 221, 224, 225].</td><td>Includes DNA, proteins, li... | <table><tr><td>Comparison</td><td>CTCs</td><td>ctDNA</td><td>Exosomes</td></tr><tr><td>Origin</td><td>Includes apoptotic tumor and viable tumor cells from a primary or metastatic tumor [71, 73].</td><td>Includes cfDNA, from the viable tumor cells or from CTCs [17, 219, 221, 224, 225].</td><td>Includes DNA, proteins, li... | <table><tr><td>Genetic materials</td><td>DNA and RNA [117, 122, 123]</td><td>DNA [17, 219, 221]</td><td>DNA and RNA [355, 357, 359–361]</td></tr><tr><td>Analytic Techniques</td><td>CellSearch [84, 148–150, 180, 182, 190], Microfluidic [187, 181], SE-iFISH [186], MetaCell [184], Immunofluorescence [181, 185, 188], Scree... |
4ec8e24ef2b6cf363185b25212e2c269630406a01807c46ab202765004cc076d.png | simple | <table><tr><td></td><td>Label</td><td>Start</td><td>Name</td><td>Function</td><td>References</td></tr><tr><td>ldRNA</td><td>BSU_misc_RNA_3</td><td>119855</td><td>ldlJ</td><td>Ribosomal protein L10 leader mRNA sequence</td><td>26101249</td></tr><tr><td>suRNA</td><td>BSU_misc_RNA_7</td><td>486092</td><td>swaO</td><td>ATP... | <table><tr><td></td><td>Label</td><td>Start</td><td>Name</td><td>Function</td><td>References</td></tr><tr><td>ldRNA</td><td>BSU_misc_RNA_3</td><td>119855</td><td>ldlJ</td><td>Ribosomal protein L10 leader mRNA sequence</td><td>26101249</td></tr><tr><td>suRNA</td><td>BSU_misc_RNA_7</td><td>486092</td><td>swaO</td><td>ATP... | <table><tr><td>suRNA</td><td>BSU_misc_RNA_8</td><td>626446</td><td>aswA</td><td>Adenine riboswitch</td><td>25573585</td></tr><tr><td>CDS</td><td>BSU09958</td><td>1071402</td><td>sscA</td><td>Spore assembly and germination protein</td><td>21670523</td></tr><tr><td>CDS</td><td>BSU09959</td><td>1071613</td><td>sscB</td><t... |
7e0c115f2494bd6816937c328d09dda63b62263eeab545736f5efd0ff3a543b1.png | complex | <table><tr><td>Characteristic</td><td colspan="2">Beijing</td><td colspan="2">Chongqing</td><td colspan="2">Guangzhou</td><td>Total</td><td></td></tr><tr><td></td><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td>Number of children</td><td>10,372</td><td>42.70%</td><td>9,846</... | <table><tr><td>Characteristic</td><td colspan="2">Beijing</td><td colspan="2">Chongqing</td><td colspan="2">Guangzhou</td><td>Total</td><td></td></tr><tr><td></td><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td>Number of children</td><td>10,372</td><td>42.70%</td><td>9,846</... | <table><tr><td>Characteristic</td><td colspan="2">Beijing</td><td colspan="2">Chongqing</td><td colspan="2">Guangzhou</td><td>Total</td><td></td></tr><tr><td></td><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td>Male</td><td>5,455</td><td>52.59%</td><td>5,258</td><td>53.40%</... |
7036e862d4b382340efe05a5924c1694bdf93c1354c374e2d625d58916cc9b9b.png | complex | <table><tr><td rowspan="2">Top 16 most significant in order</td><td rowspan="2">Chemical shift (ppm)</td><td colspan="3">I/II stage of CRC vs healthy controls</td><td rowspan="2">Related metabolomic pathway</td></tr><tr><td>VIP<sup>a</sup></td><td><i>p</i>-value<sup>b</sup></td><td>Variations vs HC</td></tr><tr><td>Cho... | <table><tr><td rowspan="2">Top 16 most significant in order</td><td rowspan="2">Chemical shift (ppm)</td></tr><tr></tr><tr><td>Choline</td><td>3.19(s)</td></tr><tr><td>Phenylalanine</td><td>3.19(m)3.98(dd)</td></tr><tr><td>Asparagine</td><td>2.80(dd)</td></tr><tr><td>Isocitrate</td><td>3.98(d)</td></tr><tr><td>Cysteine... | <table><tr><td colspan="3">I/II stage of CRC vs healthy controls</td><td rowspan="2">Related metabolomic pathway</td></tr><tr><td>VIPa</td><td>p-valueb</td><td>Variations vs HC</td></tr><tr><td>2.25</td><td>0.000</td><td>↓</td><td>Choline metabolism, Lipid metabolism</td></tr><tr><td>2.251.43</td><td>0.0000.004</td><td... |
9366449ab6e69b68f4dbe1935ab331a0faf592b946cb09a4a1268c8a2064756a.png | complex | <table><tr><td>Carbon</td><td>1</td><td>2</td><td>3</td><td>8</td><td>9</td><td>10</td></tr><tr><td>1</td><td>158.0 (s)</td><td>161.2 (s)</td><td>160.0 (s)</td><td>162.1 (s)</td><td>160.0 (s)</td><td>159.3(s)</td></tr><tr><td>2</td><td>113.5 (d)</td><td>94.3 (d)</td><td>92.7 (d)</td><td>118.2 (s)</td><td>117.5 (s)</td>... | <table><tr><td></td><td></td><td>2</td><td>3</td><td>8</td><td>9</td><td>1</td></tr></table> | <table><tr><td>Carbon</td><td>1</td><td></td><td></td><td></td><td></td><td>0</td></tr><tr><td>1</td><td>158.0 (s)</td><td>161.2 (s)</td><td>160.0 (s)</td><td>162.1 (s)</td><td>160.0 (s)</td><td>159.3(s)</td></tr><tr><td>2</td><td>113.5 (d)</td><td>94.3 (d)</td><td>92.7 (d)</td><td>118.2 (s)</td><td>117.5 (s)</td><td>1... |
169ecc289562d9a8c6099d2d0136a2798265350d8dc7be98eb11d81578e895f2.png | simple | <table><tr><td>Group</td><td>Mean ± SD</td><td>P value</td></tr><tr><td> A </td><td> 77.17±1.00 </td><td> <0.001 </td></tr><tr><td> B </td><td> 76.99±.65 </td><td> <0.001 </td></tr><tr><td> C </td><td> 78.31±1.22 </td><td> <0.001 </td></tr></table> | <table><tr><td>Group</td><td>Mean ± SD</td></tr><tr><td>A</td><td>77.17±1.00</td></tr><tr><td>B</td><td>76.99±.65</td></tr><tr><td>C</td><td>78.31±1.22</td></tr></table> | <table><tr><td>P value</td></tr><tr><td><0.001</td></tr><tr><td><0.001</td></tr><tr><td><0.001</td></tr></table> |
dbdfd24b1aafcc923730e8bcc70d3421d282e4454dfd73a4a76987449214f156.png | simple | <table><tr><td>Characteristic</td><td>HIV infected patients</td><td>Normal controls</td></tr><tr><td>Subject no.</td><td>32</td><td>35</td></tr><tr><td>Age (years, mean ± SD)</td><td>34 ± 6</td><td>36 ± 6</td></tr><tr><td>Male (No, %)</td><td>15 (46.9%)</td><td>15 (42.9%)</td></tr><tr><td>Han Ethnic (No,... | <table><tr><td>Characteristic</td><td>HIV infected patients</td><td>Normal controls</td></tr><tr><td>Subject no.</td><td>32</td><td>35</td></tr><tr><td>Age (years, mean ± SD)</td><td>34 ± 6</td><td>36 ± 6</td></tr></table> | <table><tr><td>Male (No, %)</td><td>15 (46.9%)</td><td>15 (42.9%)</td></tr><tr><td>Han Ethnic (No, %)</td><td>32 (100%)</td><td>35 (100%)</td></tr><tr><td>CD4 (cells/μL, mean ± SD)</td><td>331 ± 235</td><td>N/A</td></tr><tr><td>VL [log copies/mL (mean ± SD)]</td><td>4.15 ± 1.09</td><td>N/A</td></tr><tr><td>Time since d... |
5b3e86dab5583d65326c7cf29a4c89bd00ea520ed003b8122169bd0a23f44e55.png | simple | <table><tr><td>Model mechanism</td><td>Symbol</td><td>Mathematical expressions</td></tr><tr><td>First-order decay (<i>n</i>=1)</td><td>F1</td><td>(1–<i>α</i>)</td></tr><tr><td>Second-order decay (<i>n</i>=2)</td><td>F2</td><td>(1– <i>α</i>)<sup>2</sup></td></tr><tr><td>Third-order decay (<i>n</i>=... | <table><tr><td>Model mechanism</td><td>Symbol</td><td>Mathematical expressions</td></tr><tr><td>First-order decay (n=1)</td><td>F1</td><td>(1–α)</td></tr></table> | <table><tr><td>Second-order decay (n=2)</td><td>F2</td><td>(1– α)2</td></tr><tr><td>Third-order decay (n=3)</td><td>F3</td><td>0.5 · (1– α)3</td></tr><tr><td>Avrami-Erofeev (n=2)</td><td>A2</td><td>2 · (1– α) · [–ln(1– α)]0.5</td></tr></table> |
594cde889ce0eec7ce17826b5f3abcabd4845ab93ee4890c1011f81c2d9e796d.png | complex | <table><tr><td> </td><td> </td></tr><tr><td colspan="2">Preamble</td></tr><tr><td colspan="2">These recommendations are relevant to all practitioners and organizations communicating the new Canadian Physical Activity Guidelines for Youth. These recommendations should be used to create a clear understanding of the new C... | <table><tr><td></td><td></td></tr><tr><td colspan="2">Preamble</td></tr><tr><td colspan="2">These recommendations are relevant to all practitioners and organizations communicating the new Canadian Physical Activity Guidelines for Youth. These recommendations should be used to create a clear understanding of the new Can... | <table><tr><td rowspan="6">Motivational Messages</td><td>Move your teen to move more.</td></tr><tr><td>Life looks better with physical activity.</td></tr><tr><td>Pick a time. Pick a place. Move your teens to move more.</td></tr><tr><td>Pick a time. Pick a place. How you want to get active is up to you!</td></tr><tr><td... |
33f06199fc4f1319feb0fa811f680b22994c698eb3afa7cbb62a26ff98c33237.png | complex | <table><tr><td></td><td colspan="2">Univariable</td><td colspan="2">Multivariable</td></tr><tr><td>Variable</td><td>OR [95 % CI]</td><td><i>p</i>-value</td><td>OR [95 % CI]</td><td><i>p</i>-value</td></tr><tr><td colspan="5">Age (years)</td></tr><tr><td> 15</td><td>Ref</td><td></td><td></td><td></td></tr><tr><td> 16</t... | <table><tr><td></td><td colspan="2">Univariable</td><td colspan="2">Multivariable</td></tr><tr><td>Variable</td><td>OR [95 % CI]</td><td>p-value</td><td>OR [95 % CI]</td><td>p-value</td></tr><tr><td colspan="5">Age (years)</td></tr><tr><td>15</td><td>Ref</td><td></td><td></td><td></td></tr><tr><td>16</td><td>1.1 (0.5-2... | <table><tr><td>Tertiary</td><td>1.9 (0.2-22.8)</td><td>0.602</td><td>1.93 (0.16-22.83)</td><td>0.603</td></tr><tr><td colspan="5">Marital status</td></tr><tr><td>Never married</td><td>Ref</td><td></td><td></td><td></td></tr><tr><td>Currently or living as married</td><td>1.4 (0.6-3.1)</td><td>0.407</td><td>1.91 (0.84-4.... |
2bfd46d0c6cc9c169b6fa1ef8701370ce9e60c6721a695beb21a7a5a264081c5.png | simple | <table><tr><td>Gene</td><td>Variant</td><td>Position</td><td>OR</td><td>Common/Rare</td><td>Domain</td><td>Variant domain effect</td><td>Effect on AP</td><td>Ref</td></tr><tr><td><i>C3</i></td><td>R102G</td><td>19:6718387</td><td>1.7–2.6</td><td>Common</td><td>Macroglobulin 1</td><td>Decreased binding efficiency ... | <table><tr><td>Gene</td><td>Variant</td><td>Position</td><td>OR</td><td>Common/Rare</td><td>Domain</td><td>Variant domain effect</td><td>Effect on AP</td><td>Ref</td></tr><tr><td>C3</td><td>R102G</td><td>19:6718387</td><td>1.7–2.6</td><td>Common</td><td>Macroglobulin 1</td><td>Decreased binding efficiency of C3b to its... | <table><tr><td>C3</td><td>K155Q</td><td>19:6718146</td><td>2.8–3.8</td><td>Rare</td><td>Macroglobulin 2</td><td>Reduces binding to FH and C3b proteolytic cleavage by CFI</td><td>Increase C3 convertase production</td><td>[59, 65]</td></tr><tr><td>CFB</td><td>R32Q</td><td>6:31914180</td><td>0.32</td><td>Common</td><td>Ba... |
c22d6bd16230af5747c2b99dba4c8211fda51fc3ce7623bba5f4b908a67ac98c.png | complex | <table><tr><td>Alcohol consumption</td><td><i>MTHFR</i> genotype</td><td>Cases <i>n</i> (%)</td><td>Controls <i>n</i> (%)</td><td>Age-adjusted OR (95% CI)</td></tr><tr><td>Low</td><td>CC</td><td>3 (8)</td><td>29 (20)</td><td>1.00 (ref)</td></tr><tr><td>Low</td><td>CT + TT</td><td>5 (14)</td><td>39 (27)</td><td>1.25 (0.... | <table><tr><td>Alcohol consumption</td><td>MTHFR genotype</td><td>Cases n (%)</td><td>Controls n (%)</td><td>Age-adjusted OR (95% CI)</td></tr></table> | <table><tr><td>Low</td><td>CC</td><td>3 (8)</td><td>29 (20)</td><td>1.00 (ref)</td></tr><tr><td>Low</td><td>CT + TT</td><td>5 (14)</td><td>39 (27)</td><td>1.25 (0.28–5.65)</td></tr><tr><td>High</td><td>CC</td><td>14 (38)</td><td>31 (21)</td><td>4.43 (1.15–17.05)</td></tr><tr><td>High</td><td>CT + TT</td><td>15 (41)</td... |
9e638d3f409a1f9a16992fa4ff67b71549bcc52be8ae571c1736302c8a0e5f54.png | simple | <table><tr><td>Variable</td><td>Women alive (0) (n)%</td><td>Women dead (1) (n)%</td><td>P-value</td></tr><tr><td>Overall (n = 42,703)</td><td>(n = 39,605) 92.75</td><td>(n = 3,098) 7.25</td><td></td></tr><tr><td>Age in years at entry</td><td></td><td></td><td><0.001</td></tr><tr><td> 15–19</td><td>(18,220) 46... | <table><tr><td>Variable</td><td>Women alive (0) (n)%</td><td>Women dead (1) (n)%</td><td>P-value</td></tr><tr><td>Overall (n = 42,703)</td><td>(n = 39,605) 92.75</td><td>(n = 3,098) 7.25</td><td></td></tr><tr><td>Age in years at entry</td><td></td><td></td><td><0.001</td></tr><tr><td>15–19</td><td>(18,220) 46.0</td><td... | <table><tr><td>All live births</td><td>(22,005) 55.56</td><td>(1,917) 61.88</td></tr><tr><td>≥ 1 pregnancy was a still birth</td><td>(29,68) 7.49</td><td>(317) 10.23</td></tr><tr><td>No outcome reported</td><td>(14,632) 36.94</td><td>(864) 27.89</td></tr></table> |
7268e95d57581cf5389c15adb7a8f305cf6576a1f447bf6610bbbd881460821a.png | complex | <table><tr><td>Model</td><td colspan="2">Fatal + non-fatal events</td><td colspan="2">Fatal events</td></tr><tr><td></td><td>Women</td><td>Men</td><td>Women</td><td>Men</td></tr><tr><td>Crude</td><td>1.16 (1.04–1.29</td><td>1.05 (0.96–1.15)</td><td>1.27(1.04–1.55)</td><td>1.24 (1.02–1.50)</td></... | <table><tr><td>Model</td><td colspan="2">Fatal + non-fatal events</td><td colspan="2">Fatal events</td></tr><tr><td></td><td>Women</td><td>Men</td><td>Women</td><td>Men</td></tr><tr><td>Cru</td><td>1.16</td><td>1.05 (0.96</td><td>1.27(1.04–1.55</td><td>1.24 (</td></tr></table> | <table><tr><td>de</td><td> (1.04–1.29</td><td>–1.15)</td><td>)</td><td>1.02–1.50)</td></tr><tr><td>Adjusted*</td><td>1.06 (0.95–1.17)</td><td>0.96 (0.88–1.06)</td><td>1.11 (0.91–1.35)</td><td>1.09 (0.90–1.33)</td></tr></table> |
e8f5028f27c6bac2e7f89fe19e3df177ddeb90fd5d8eb0fb5352ef1eb236c530.png | simple | <table><tr><td>Formulation</td><td>Hardness (kg/cm<sup>2</sup>)</td><td>Friability (%)</td><td>%Drug content</td><td>Disintegration time (sec.)</td></tr><tr><td>S1</td><td>3.6±0.17</td><td>0.61±0.10</td><td>98.99±0.3</td><td>67.4±1.2</td></tr><tr><td>S2</td><td>3.7±0.11</td><td>0.67±0.11</... | <table><tr><td>Formulation</td><td>Hardness (kg/cm2)</td><td>Friability (%)</td><td>%Drug content</td><td>Disintegration time (sec.)</td></tr><tr><td>S</td><td>3.6±0.</td><td>0.61±0.</td><td>98.99±0</td><td>67.4±1.</td></tr></table> | <table><tr><td>1</td><td>17</td><td>10</td><td>.3</td><td>2</td></tr><tr><td>S2</td><td>3.7±0.11</td><td>0.67±0.11</td><td>99.29±0.7</td><td>38.5±1.8</td></tr><tr><td>S3</td><td>3.3±0.15</td><td>0.65±0.11</td><td>99.45±0.11</td><td>42.1±1.3</td></tr><tr><td>S4</td><td>3.8±0.11</td><td>0.63±0.15</td><td>99.75±0.15</td><... |
f7404d2122c2a7a259d61de2d00ad71a52db1ffd7b61a8813f74e92ef7b769ec.png | complex | <table><tr><td rowspan="3">Peak torque (Nm)</td><td colspan="3">Mean ± SD</td><td>Within</td><td>Between</td><td>All</td><td rowspan="3">P-value</td><td>95% CI</td><td>SEM (%) ±</td></tr><tr><td>Session 1</td><td>Session 2</td><td>Session 3</td><td>ICC (2–3)</td><td>ICC (1–2)</td><td>ICC</td><td>l... | <table><tr><td rowspan="3">Peak torque (Nm)</td><td>Mean ± SD</td></tr><tr><td>Session 1</td></tr><tr><td></td></tr><tr><td>Quadriceps right</td><td></td></tr><tr><td>Concentric at 60os−1</td><td>229.4 ± 37.5</td></tr><tr><td>Isometric</td><td>257.8 ± 46.9</td></tr><tr><td>Eccentric at 60os−1</td><td>303.0 ± 63.6</td><... | <table><tr><td colspan="2">Mean ± SD</td><td>Within</td><td>Between</td><td>All</td><td rowspan="3">P-value</td><td>95% CI</td><td>SEM (%) ±</td></tr><tr><td>Session 2</td><td>Session 3</td><td>ICC (2–3)</td><td>ICC (1–2)</td><td>ICC</td><td>lower; upper</td><td>MDC (%)</td></tr><tr><td colspan="5"></td><td colspan="2"... |
52a8ec39a031137a21941b7c8a419315613e62a894b0e4ec82842404bab9f0ee.png | complex | <table><tr><td rowspan="2"></td><td colspan="2">Age < 65 (<i>n</i> = 43)</td><td colspan="2">Age ≥ 65 (<i>n</i> = 23)</td><td rowspan="2"><i>P</i> Value</td></tr><tr><td>Mean</td><td>Std Dev</td><td>Mean</td><td>Std Dev</td></tr><tr><td>Volume</td><td>1610.9</td><td>395.6</td><td>1677.6</td><td>434.6</td><td>0... | <table><tr><td rowspan="2"></td><td colspan="2">Age < 65 (n = 43)</td><td colspan="2">Age ≥ 65 (n = 23)</td><td rowspan="2">P Value</td></tr><tr><td>Mean</td><td>Std Dev</td><td>Mean</td><td>Std Dev</td></tr><tr><td>Volume</td><td>1610.9</td><td>395.6</td><td>1677.6</td><td>434.6</td><td>0.61</td></tr><tr><td>D98%</td>... | <table><tr><td rowspan="2"></td><td colspan="2">Age < 65 (n = 43)</td><td colspan="2">Age ≥ 65 (n = 23)</td><td rowspan="2">P Value</td></tr><tr><td>Mean</td><td>Std Dev</td><td>Mean</td><td>Std Dev</td></tr><tr><td>D2%</td><td>53.9</td><td>1.5</td><td>53.9</td><td>1.3</td><td>0.61</td></tr><tr><td>Median</td><td>51.7<... |
6250736ab3ba69a93d9a47df56ce822b8245cbbab024a7a4d048eaa990bc357f.png | complex | <table><tr><td></td><td colspan="3">Strain detected</td></tr><tr><td>Pathogen</td><td>Only by BC</td><td>Only by Septi<i>Fast</i></td><td>Both methods</td></tr><tr><td><i>S.aureus </i>(MSSA)</td><td>0</td><td>3</td><td>3</td></tr><tr><td><i>S.aureus </i>(MRSA)</td><td>2</td><td>0</td><td>4</td></tr><tr><td><i>S.pneumon... | <table><tr><td></td><td colspan="2">Strain detected</td></tr><tr><td>Pathogen</td><td>Only by BC</td><td>Only by SeptiFast</td></tr><tr><td>S.aureus (MSSA)</td><td>0</td><td>3</td></tr><tr><td>S.aureus (MRSA)</td><td>2</td><td>0</td></tr><tr><td>S.pneumoniae</td><td>0</td><td>1</td></tr><tr><td>Streptococcus spp.</td><... | <table><tr><td>Strain detected</td></tr><tr><td>Both methods</td></tr><tr><td>3</td></tr><tr><td>4</td></tr><tr><td>0</td></tr><tr><td>1</td></tr><tr><td>0</td></tr><tr><td>0</td></tr><tr><td>1</td></tr><tr><td>9</td></tr><tr><td>1</td></tr><tr><td>1</td></tr><tr><td>0</td></tr><tr><td>1</td></tr><tr><td>21</td></tr><t... |
6492bdee0228ba49bce41f716fd289652156e52866864fd0726a71e4cef2761e.png | complex | <table><tr><td>Negative binomial counts > 0</td><td colspan="3">Univariate</td><td colspan="3">Multivariable</td></tr><tr><td>Variable</td><td>IRR</td><td colspan="2">95 % CI</td><td>IRR</td><td colspan="2">95 % CI</td></tr><tr><td>No. of persons sleeping in house</td><td>0.902</td><td>0.740</td><td>1.100</td><td>&#... | <table><tr><td>Negative binomial counts > 0</td><td colspan="3">Univariate</td><td colspan="3">Multivariable</td></tr></table> | <table><tr><td>Variable</td><td>IRR</td><td colspan="2">95 % CI</td><td>IRR</td><td colspan="2">95 % CI</td></tr><tr><td>No. of persons sleeping in house</td><td>0.902</td><td>0.740</td><td>1.100</td><td>–</td><td>–</td><td>–</td></tr><tr><td>No. of ITNs per house</td><td>0.559*</td><td>0.349*</td><td>0.897*</td><td>–<... |
dd9ce572d5da07b19f1775ed517aac7d6762d73c535ba443d8ffa15c159b85f6.png | simple | <table><tr><td>Year</td><td>Authors</td><td>Age, gender</td><td>Concurrent malignancy (location)</td><td>Past history of recurrence</td><td>Diagnostic modality</td></tr><tr><td>2015</td><td>Jerraya H, et al.</td><td>59, F</td><td>Insulinoma (pancreas)</td><td>NA</td><td>NA</td></tr><tr><td>2015</td><td>Jung SY, et al.<... | <table><tr><td>Year</td><td>Authors</td><td>Age, gender</td><td>Concurrent malignancy (location)</td><td>Past history of recurrence</td><td>Diagnostic modality</td></tr><tr><td>2015</td><td>Jerraya H, et al.</td><td>59, F</td><td>Insulinoma (pancreas)</td><td>NA</td><td>NA</td></tr></table> | <table><tr><td>Year</td><td>Authors</td><td>Age, gender</td><td>Concurrent malignancy (location)</td><td>Past history of recurrence</td><td>Diagnostic modality</td></tr><tr><td>2015</td><td>Jung SY, et al.</td><td>11, F</td><td>Insulinoma (pancreas)</td><td>Non</td><td>US, CT, MRI</td></tr><tr><td>2009</td><td>Wheeler ... |
950caf77042c9f4b6df15b0fb0dd41085733635542994424746e68b0135e54b8.png | complex | <table><tr><td> </td><td>LOO AUC (SE)</td><td>Sensitivity</td><td>Specificity</td><td>Median number of peaks per LOO iteration</td><td>Mean number of peaks per LOO iteration (SD)</td></tr><tr><td colspan="6">Lymph node status</td></tr><tr><td> Negative <i>vs</i> Positive</td><td>0.95 (0.03)</td><td>73.9</td><td>91.7</t... | <table><tr><td></td><td>LOO AUC (SE)</td><td>Sensitivity</td><td>Specificity</td></tr><tr><td colspan="4">Lymph node status</td></tr><tr><td>Negative vs Positive</td><td>0.95 (0.03)</td><td>73.9</td><td>91.7</td></tr><tr><td colspan="4">Histological subtype</td></tr><tr><td>Squamous ca. vs adenoca.</td><td>0.88 (0.05)<... | <table><tr><td>Median number of peaks per LOO iteration</td><td>Mean number of peaks per LOO iteration (SD)</td></tr><tr><td colspan="2">Lymph node status</td></tr><tr><td>1</td><td>1 (0)</td></tr><tr><td colspan="2">Histological subtype</td></tr><tr><td>1</td><td>1 (0)</td></tr><tr><td>4</td><td>3.8 (0.9)</td></tr><tr... |
cf4c1fe390827f3abbe47b4b55f647ad8224884be95a3dffb9b773555480bb8a.png | simple | <table><tr><td></td><td>Annual expenses ($)</td></tr><tr><td>Annual cost of mobile health clinic</td><td>565,700</td></tr><tr><td>Total annual visits</td><td>4,848</td></tr><tr><td>Total visits discounted by 20%</td><td>3,878</td></tr><tr><td>Cost per visit</td><td>117</td></tr><tr><td>Cost of preventable emergency dep... | <table><tr><td></td></tr><tr><td>Annual cost of mobile health clinic</td></tr><tr><td>Total annual visits</td></tr><tr><td>Total visits discounted by 20%</td></tr><tr><td>Cost per visit</td></tr><tr><td>Cost of preventable emergency department visit [9]</td></tr><tr><td>Cost avoided per mobile clinic visit</td></tr><tr... | <table><tr><td>Annual expenses ($)</td></tr><tr><td>565,700</td></tr><tr><td>4,848</td></tr><tr><td>3,878</td></tr><tr><td>117</td></tr><tr><td>923</td></tr><tr><td>806</td></tr><tr><td>3,125,668</td></tr></table> |
4e459f840eace4d1d2ebd55c5a51a7eb48330fd7a8da3f511c1b547e67668444.png | complex | <table><tr><td>Cohorts</td><td>TCGA</td><td>TCGA-sub</td><td>RT-qPCR</td><td>Ivshina</td><td>Schmidt</td><td>Symmans</td><td>Wang</td></tr><tr><td>N</td><td>520</td><td>59</td><td>71</td><td>249</td><td>200</td><td>298</td><td>286</td></tr><tr><td colspan="8">Histological type</td></tr><tr><td> Ductal</td><td>442 (85.0... | <table><tr><td>Cohorts</td><td>TCGA</td><td>TCGA-sub</td><td>RT-qPCR</td><td>Ivshina</td><td>Schmidt</td><td>Symmans</td><td>Wang</td></tr><tr><td>N</td><td>520</td><td>59</td><td>71</td><td>249</td><td>200</td><td>298</td><td>286</td></tr><tr><td colspan="8">Histological type</td></tr><tr><td>Ductal</td><td>442 (85.0)... | <table><tr><td>IV</td><td>14 (2.7)</td><td>1 (1.7)</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td></tr><tr><td colspan="8">Tumour grade</td></tr><tr><td>Grade 1</td><td>–</td><td>–</td><td>7 (9.9)</td><td>68 (27.3)</td><td>29 (14.5)</td><td>–</td><td>–</td></tr><tr><td>Grade 2</td><td>–</td><td>–</td><td>25 (35.... |
cf4a2a09e80683961e3b1d159dd317d92bfbab52ddcba21e3c03f26cf8bd6483.png | simple | <table><tr><td>Primer</td><td>Gene</td><td>Sequence</td><td>Fragment size (bp)</td></tr><tr><td>rpoB-FS</td><td></td><td>TGGTCCGCTTGCACGAGGGTCAGA</td><td></td></tr><tr><td></td><td><i>rpoB</i></td><td></td><td>758</td></tr><tr><td>rpoB-RS</td><td></td><td>CAGGAAGGGAATCATCGCGG</td><td></td></tr><tr><td>katG-FS</td><td><... | <table><tr><td>Primer</td><td>Gene</td><td>Sequence</td><td>Fragment size (bp)</td></tr><tr><td>rpoB-FS</td><td></td><td>TGGTCCGCTTGCACGAGGGTCAGA</td><td></td></tr><tr><td></td><td>rpoB</td><td></td><td>758</td></tr><tr><td>rpoB-RS</td><td></td><td>CAGGAAGGGAATCATCGCGG</td><td></td></tr><tr><td>katG-FS</td><td></td><td... | <table><tr><td>katG-RS</td><td></td><td></td><td></td></tr><tr><td>inhA-FS</td><td></td><td>ACATACCTGCTGCGCAAT</td><td></td></tr><tr><td></td><td>inhA</td><td>TCACATTCGACGCCAAAC</td><td>400</td></tr><tr><td>inhA-RS</td><td></td><td></td><td></td></tr></table> |
43d434a1d8023044b539a3aec21d08c6cfe499e5d281b27a8ef10f9edea5ffee.png | simple | <table><tr><td>Toxo DB type<sup>a</sup></td><td>No. of isolates</td><td>Designation</td></tr><tr><td>9, (Chinese1)</td><td>1</td><td>TgDgCo4</td></tr><tr><td>10 (Type I)</td><td>2</td><td>TgCtCo 2, 7</td></tr><tr><td>14</td><td>6</td><td>TgDgCo9,12,15,18; TgCkCo2;TgCtco14</td></tr><tr><td>18</td><td>3</td><td>TgCtCo 12... | <table><tr><td>Toxo DB typea</td><td>No. of isolates</td><td>Designation</td></tr><tr><td>9, (Chinese1)</td><td>1</td><td>TgDgCo4</td></tr><tr><td>10 (Type I)</td><td>2</td><td>TgCtCo 2, 7</td></tr><tr><td>14</td><td>6</td><td>TgDgCo9,12,15,18; TgCkCo2;TgCtco14</td></tr><tr><td>18</td><td>3</td><td>TgCtCo 12, 13; TgDgC... | <table><tr><td>Toxo DB typea</td><td>No. of isolates</td><td>Designation</td></tr><tr><td>122</td><td>1</td><td>TgDgCo7</td></tr><tr><td>128</td><td>1</td><td>TgCtCo8</td></tr><tr><td>178</td><td>1</td><td>TgCkCo4</td></tr><tr><td>179</td><td>2</td><td>TgCkCo17,22</td></tr><tr><td>188</td><td>1</td><td>TgCkCo9</td></tr... |
f30833786152e08c8a50f4e1e1592835cf4fa19934e058265ab492341301d2ef.png | complex | <table><tr><td>Region-based test result</td><td colspan="2">Truth</td><td></td></tr><tr><td></td><td>True H<sub><i>A</i></sub></td><td>True H<sub>0</sub></td><td>Total</td></tr><tr><td><i>p</i>-value < Threshold: reject null hypothesis</td><td>A</td><td>C</td><td>A + C</td></tr><tr><td><i>p</i>-value ≥ Thresho... | <table><tr><td>Region-based test result</td><td colspan="2">Truth</td><td></td></tr></table> | <table><tr><td></td><td>True HA</td><td>True H0</td><td>Total</td></tr><tr><td>p-value < Threshold: reject null hypothesis</td><td>A</td><td>C</td><td>A + C</td></tr><tr><td>p-value ≥ Threshold: do not reject null hypothesis</td><td>B</td><td>D</td><td>B + D</td></tr><tr><td>Total</td><td>A + B</td><td>C + D</td><td></... |
9d2fd4f88cc8a74873254147a9dbf6838208cc2c14919434d11c8ef9be9ed5fc.png | complex | <table><tr><td></td><td colspan="2">Informatively cued letter-parity task</td><td colspan="2">Non-informatively cued letter-parity task</td><td colspan="2">Informatively cued color-shape task</td></tr><tr><td></td><td>Young</td><td>Older</td><td>Young</td><td>Older</td><td>Young</td><td>Older</td></tr><tr><td>Hits</td>... | <table><tr><td></td><td colspan="2">Informatively cued letter-parity task</td><td colspan="2">Non-informatively cued letter-parity task</td><td colspan="2">Informatively cued color-shape task</td></tr><tr><td></td><td>Young</td><td>Older</td><td>Young</td><td>Older</td><td>Young</td><td>Older</td></tr><tr><td>Hits</td>... | <table><tr><td></td><td colspan="2">Informatively cued letter-parity task</td><td colspan="2">Non-informatively cued letter-parity task</td><td colspan="2">Informatively cued color-shape task</td></tr><tr><td></td><td>Young</td><td>Older</td><td>Young</td><td>Older</td><td>Young</td><td>Older</td></tr><tr><td>TR</td><t... |
53b503b93f773930fa034bde2f0d0643d4693b5350b353e2f9553aaf0cc4e28e.png | complex | <table><tr><td colspan="2">Items</td><td>Cu NPs</td><td>Cu MPs</td></tr><tr><td colspan="2">Shape</td><td>Spherical</td><td>Spherical</td></tr><tr><td colspan="2">Primary size<sup>a</sup></td><td>32.7 ± 10.5 nm</td><td>25.3 ± 6.6 μm</td></tr><tr><td rowspan="3">Hydrodynamic size (nm)<sup>b</sup></td><td>... | <table><tr><td>Items</td></tr><tr><td>Shape</td></tr><tr><td>Primary sizea</td></tr><tr><td rowspan="3">Hydrodynamic size (nm)b</td></tr><tr></tr><tr></tr><tr><td>Surface area (m2/g)c</td></tr><tr><td rowspan="3">Zeta potential (mV)d</td></tr><tr></tr><tr></tr></table> | <table><tr><td>Items</td><td>Cu NPs</td><td>Cu MPs</td></tr><tr><td>Shape</td><td>Spherical</td><td>Spherical</td></tr><tr><td>Primary sizea</td><td>32.7 ± 10.5 nm</td><td>25.3 ± 6.6 μm</td></tr><tr><td>pH 1.5</td><td>n.a</td><td>n.a</td></tr><tr><td>pH 6.5</td><td>516 ± 116.9</td><td>n.a</td></tr><tr><td>pH 7.8</td><t... |
3be8cb4ea3df62c05ab615669ec86b06457febdd2371515aaa6217169a780233.png | simple | <table><tr><td>Category label</td><td>Observed average</td><td>Infit MNSQ</td><td>Outfit MNSQ</td><td>Structure calibration</td></tr><tr><td>1</td><td>-23.71</td><td>1.10</td><td>41.06</td><td>None</td></tr><tr><td>2</td><td>-14.67</td><td>1.01</td><td>.99</td><td>-21.95</td></tr><tr><td>3</td><td>-5.31</td><td>0.98</t... | <table><tr><td>Category label</td><td>Observed average</td><td>Infit MNSQ</td><td>Outfit MNSQ</td><td>Structure calibration</td></tr><tr><td>1</td><td>-23.71</td><td>1.10</td><td>41.06</td><td>None</td></tr><tr><td>2</td><td>-14.67</td><td>1.01</td><td>.99</td><td>-21.95</td></tr><tr><td>3</td><td>-5.31</td><td>0.98</t... | <table><tr><td>Category label</td><td>Observed average</td><td>Infit MNSQ</td><td>Outfit MNSQ</td><td>Structure calibration</td></tr><tr><td>6</td><td>16.12</td><td>.93</td><td>.94</td><td>20.07</td></tr></table> |
885cc5cfe3ff7f585fd20f6e0f22dae28bb0c412097e61869cfa157f1cc4d31b.png | simple | <table><tr><td> </td><td><i>β</i> intercept (standardised coefficient)</td><td><i>P </i>value</td></tr><tr><td>Height</td><td>0.094</td><td>0.48</td></tr><tr><td>Weight</td><td>0.003</td><td>0.98</td></tr><tr><td>Fat%</td><td>0.058</td><td>0.53</td></tr><tr><td>Physical activity</td><td>0.215</td><td><0.01</td>... | <table><tr><td></td><td>β intercept (standardised coefficient)</td><td>P value</td></tr><tr><td>Height</td><td>0.094</td><td>0.48</td></tr><tr><td>Weight</td><td>0.003</td><td>0.98</td></tr><tr><td>Fat%</td><td>0.058</td><td>0.53</td></tr><tr><td>Physical activity</td><td>0.215</td><td><0.01</td></tr></table> | <table><tr><td></td><td>β intercept (standardised coefficient)</td><td>P value</td></tr><tr><td>Age of onset of diabetes</td><td>0.16</td><td>0.09</td></tr><tr><td>Duration of diabetes</td><td>−0.046</td><td>0.56</td></tr><tr><td>HbA1c</td><td>−0.451</td><td><0.01</td></tr><tr><td>Insulin dose</td><td>0.20</td><td>0.07... |
c858b01687efc1fb43310cdac6c0fbf1ce8ad4c0d285adf8e4c033d38cbdd078.png | simple | <table><tr><td>Parameter</td><td>Meaning</td><td>Value</td></tr><tr><td><i>kphr</i></td><td>Phosphorylation of RsbR</td><td>0.1 / 1</td></tr><tr><td><i>kdpr</i></td><td>Dephosphorylation of RsbR-P</td><td>0.06</td></tr><tr><td><i>kphs</i></td><td>Phosphorylation of RsbS</td><td>0.4</td></tr><tr><td><i>kdps</i></td><td>... | <table><tr><td>Parameter</td><td>Meaning</td><td>Value</td></tr><tr><td>kphr</td><td>Phosphorylation of RsbR</td><td>0.1 / 1</td></tr><tr><td>kdpr</td><td>Dephosphorylation of RsbR-P</td><td>0.06</td></tr></table> | <table><tr><td>kphs</td><td>Phosphorylation of RsbS</td><td>0.4</td></tr><tr><td>kdps</td><td>Dephosphorylation of RsbS-P</td><td>1</td></tr></table> |
22cdd35500f2a7305afb9078853f0bf78c9bb9cb9c3f032a40b12fb1f212ed33.png | simple | <table><tr><td>Ethnic Genotype</td><td><i>N</i></td><td>TC (mmol/l)</td><td>TAG (mmol/l)</td><td>HDL-C (mmol/l)</td><td>LDL-C (mmol/)</td><td>Apo A1 (g/l)</td><td>ApoB (g/l)</td><td>ApoA1/ApoB</td></tr><tr><td>Han</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> CC</td><td>566</... | <table><tr><td>Ethnic Genotype</td><td>N</td><td>TC (mmol/l)</td><td>TAG (mmol/l)</td><td>HDL-C (mmol/l)</td><td>LDL-C (mmol/)</td><td>Apo A1 (g/l)</td><td>ApoB (g/l)</td><td>ApoA1/ApoB</td></tr><tr><td>Han</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>CC</td><td>566</td><td>5... | <table><tr><td></td><td></td><td>3</td><td>4</td><td>725</td><td>.974</td><td>21</td><td>50</td><td></td></tr><tr><td>P</td><td></td><td>0.017</td><td>0.949</td><td>0.000</td><td>0.140</td><td>0.133</td><td>0.009</td><td>0.000</td></tr><tr><td>Mulao</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td... |
06dbb998915a8a9b9f48690741ecffb12898e68ff6aeacb4ac9a41fb7b29b93d.png | simple | <table><tr><td></td><td>Sex</td><td>Age</td><td>Pituitary MRI</td><td>Internal carotid RMI</td><td>Other characteristics</td><td>Molecular studies</td><td>References</td></tr><tr><td>1</td><td>N</td><td>N</td><td>Not specified (except for normal posterior pituitary).</td><td>Absence of ICA and carotid canal.</td><td>No... | <table><tr><td></td><td>Sex</td><td>Age</td><td>Pituitary MRI</td><td>Internal carotid RMI</td><td>Other characteristics</td><td>Molecular studies</td><td>References</td></tr><tr><td>1</td><td>N</td><td>N</td><td>Not specified (except for normal posterior pituitary).</td><td>Absence of ICA and carotid canal.</td><td>No... | <table><tr><td>13</td><td>M</td><td>17 year</td><td>Adenohypophyseal hypoplasia with a lack of posterior pituitary hyperintensity</td><td>Agenesis of the left ICA</td><td>GH deficiency. No other pituitary deficiencies. No clinical evidence of diabetes insipidus.</td><td>Normal array-CGH</td><td>Our case</td></tr></tabl... |
9b60f3b7feec610bd3c0841a19627ca6a8c8836a93105d8fbb61db37800db6f9.png | simple | <table><tr><td>#</td><td>SET I (8-week-old)</td><td>Summary</td></tr><tr><td>1</td><td>Control diet (CD)</td><td>Peliosis, nuclear dysplasia and nuclear retreat.</td></tr><tr><td>2</td><td>CD + Quercetin</td><td>Small & large lymphoplasmacytic clusters.</td></tr><tr><td>3</td><td>CD + δ-Tocotrienol</td><td>Lar... | <table><tr><td>#</td><td>SET I (8-week-old)</td><td>Summary</td></tr><tr><td>1</td><td>Control diet (CD)</td><td>Peliosis, nuclear dysplasia and nuclear retreat.</td></tr><tr><td>2</td><td>CD + Quercetin</td><td>Small & large lymphoplasmacytic clusters.</td></tr><tr><td>3</td><td>CD + δ-Tocotrienol</td><td>Large lympho... | <table><tr><td>#</td><td>SET I (8-week-old)</td><td>Summary</td></tr><tr><td></td><td>diet (CD)</td><td>ovesicular steatosis.</td></tr><tr><td>6</td><td>CD + Quercetin</td><td>Coucilman body, nuclear dysplasia and nuclear retreat.</td></tr><tr><td>7</td><td>CD + δ-Tocotrienol</td><td>Small & large Lymphoplasmacytic clu... |
9ea21e3efd5defafa0d9988f3696cc2769bde9d29c6a42616a6fd689cfd3f5ca.png | simple | <table><tr><td></td><td>TLE (<i>n</i> = 20)</td><td>Controls (<i>n</i> = 12)</td></tr><tr><td>Age</td><td>33.60 (7.32)</td><td>31.58 (3.03)</td></tr><tr><td>Years of education</td><td>15.35 (1.98)</td><td>16.75 (1.14)</td></tr><tr><td>Duration of epilepsy (years)</td><td>20.40 (11.22)</td><td></td></tr><tr><td>Age at e... | <table><tr><td></td><td>TLE (n = 20)</td><td>Controls (n = 12)</td></tr></table> | <table><tr><td>Age</td><td>33.60 (7.32)</td><td>31.58 (3.03)</td></tr><tr><td>Years of education</td><td>15.35 (1.98)</td><td>16.75 (1.14)</td></tr><tr><td>Duration of epilepsy (years)</td><td>20.40 (11.22)</td><td></td></tr><tr><td>Age at epilepsy onset (years)</td><td>13.65 (8.67)</td><td></td></tr><tr><td>Seizure fr... |
80b98ef55f29fa1f3bbc5ce93effc1bd1aa7d0724340ef49c678c4baaefc67f9.png | simple | <table><tr><td>Acronym</td><td>Description</td><td>Source</td></tr><tr><td>GDP</td><td>Gross Domestic Product per capita (PPS$), i.e. a measure of the economic activity and of the wealth of a country.</td><td>(1)</td></tr><tr><td>Real GDP Growth rate</td><td>The growth rate of the GDP in terms of volume (%), values det... | <table><tr><td>Acronym</td><td>Description</td><td>Source</td></tr><tr><td>GDP</td><td>Gross Domestic Product per capita (PPS$), i.e. a measure of the economic activity and of the wealth of a country.</td><td>(1)</td></tr><tr><td>Real GDP Growth rate</td><td>The growth rate of the GDP in terms of volume (%), values det... | <table><tr><td>U</td><td>Unemployment rate (%), i.e. the percentage of unemployed people in the active population.</td><td>(3)</td></tr></table> |
5879162caae63451938a6c91a246a04a7bdc1457b5c3c1d5f77d9cdd559565bf.png | simple | <table><tr><td>Variable</td><td>Mean</td><td>95% CI</td></tr><tr><td>Children seen per day</td><td>1.8</td><td>1.8-1.9</td></tr><tr><td>Time spent on seeing children (hrs)/day</td><td>0.4</td><td>20.9-21.1</td></tr><tr><td>No of Health education activities/day</td><td>2.5</td><td>2.3-2.6</td></tr><tr><td>Time spent on ... | <table><tr><td>Variable</td><td>Mean</td><td>95% CI</td></tr><tr><td>Children seen per day</td><td>1.8</td><td>1.8-1.9</td></tr></table> | <table><tr><td>Time spent on seeing children (hrs)/day</td><td>0.4</td><td>20.9-21.1</td></tr><tr><td>No of Health education activities/day</td><td>2.5</td><td>2.3-2.6</td></tr><tr><td>Time spent on IEC (hrs)</td><td>0.2</td><td>11.4-12.8</td></tr><tr><td>Follow-ups/day</td><td>**2.6</td><td>2.4-2.8</td></tr><tr><td>Ho... |
9903da823ec0027f737b7a783abd1d846502b3f6d7661a9a88a2fd6be4eb736a.png | complex | <table><tr><td>Study</td><td>Cell type</td><td>Treatment</td><td>Time points</td><td>Array</td></tr><tr><td colspan="5">Expression profiling studies on 3T3-L1 cell line</td></tr><tr><td>Guo <i>et al</i>. 2000 [14]</td><td>3T3-L1</td><td>DMI</td><td>0h, 6d</td><td>18k mouse cDNA filter arrays</td></tr><tr><td>Soukas <i>... | <table><tr><td>Study</td><td>Cell type</td><td>Treatment</td><td>Time points</td><td>Array</td></tr><tr><td colspan="5">Expression profiling studies on 3T3-L1 cell line</td></tr><tr><td>Guo et al. 2000 [14]</td><td>3T3-L1</td><td>DMI</td><td>0h, 6d</td><td>18k mouse cDNA filter arrays</td></tr><tr><td>Soukas et al. 200... | <table><tr><td>005 [23]</td><td></td><td>I</td><td></td><td>MOE430A</td></tr><tr><td>Pantoja et al. 2005 [24]</td><td>3T3-L1</td><td>D↔M I| M↔D I</td><td></td><td>38 k MEEBO microarray oligo set</td></tr><tr><td colspan="5">Adipogenesis expression studies on other mouse cell models including over-expression and knock o... |
b47096b214685cb13aa2ff67d4c21498ceea16ffc2207f1fa00ebe3a91d8b42b.png | simple | <table><tr><td>Indicator</td><td><i>r</i></td><td><i>p</i> value</td></tr><tr><td>GDP</td><td>0.812</td><td>0.000</td></tr><tr><td>GERD</td><td>0.758</td><td>0.000</td></tr><tr><td>RDP</td><td>0.533</td><td>0.000</td></tr><tr><td>NP</td><td>0.804</td><td>0.000</td></tr><tr><td>NC</td><td>0.837</td><td>0.000</td></tr><t... | <table><tr><td>Indicator</td><td>r</td></tr><tr><td>GDP</td><td>0.812</td></tr><tr><td>GERD</td><td>0.758</td></tr><tr><td>RDP</td><td>0.533</td></tr><tr><td>NP</td><td>0.804</td></tr><tr><td>NC</td><td>0.837</td></tr><tr><td>NTP</td><td>0.822</td></tr></table> | <table><tr><td>p value</td></tr><tr><td>0.000</td></tr><tr><td>0.000</td></tr><tr><td>0.000</td></tr><tr><td>0.000</td></tr><tr><td>0.000</td></tr><tr><td>0.000</td></tr></table> |
004228d4237dd5855fe1f2e80649d08b8c054a3bd7097a00c6e402e2b776e61a.png | complex | <table><tr><td>Characteristic</td><td>Crude odds ratios with 95% confidence interval</td><td>Adjusted odds ratios with 95% confidence interval</td></tr><tr><td>Age above 25 years</td><td>1.65 (1.33-2.04)*</td><td>.74 (.54-1.02)</td></tr><tr><td>Age 24 years & below -Ref</td><td> </td><td> </td></tr><tr><td>Income 5... | <table><tr><td>Characteristic</td><td>Crude odds ratios with 95% confidence interval</td><td>Adjusted odds ratios with 95% confidence interval</td></tr></table> | <table><tr><td>Age above 25 years</td><td>1.65 (1.33-2.04)*</td><td>.74 (.54-1.02)</td></tr><tr><td>Age 24 years & below -Ref</td><td></td><td></td></tr><tr><td>Income 5001 NPR or above</td><td>.85 (.71-1.00)</td><td>1.30 (1.04-1.62)**</td></tr><tr><td>5000 NPR or less/month- Ref</td><td></td><td></td></tr><tr><td>Educ... |
774d024d051ce934b0ab07250a2dbf04ed70ed8d9636c8a78036e7c3b7780b48.png | complex | <table><tr><td rowspan="3">Variable</td><td colspan="2">HZ patients(<i>n</i> = 38 743)</td><td colspan="2">Comparison patients(<i>n</i> = 116 229)</td><td rowspan="3"><i>P</i> value</td></tr><tr><td><i>n</i></td><td>%</td><td><i>n</i></td><td>%</td></tr><tr><td>Sex</td><td> </td><td> </td><td> </td><td> </td><td> </td>... | <table><tr><td rowspan="3">Variable</td><td colspan="2">HZ patients(n = 38 743)</td><td colspan="2">Comparison patients(n = 116 229)</td><td rowspan="3">P value</td></tr><tr><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td colspan="4"></td></tr><tr><td>Sex</td><td></td><td></td><td></td><td></td><td></td></tr><tr><... | <table><tr><td rowspan="3">Variable</td><td colspan="2">HZ patients(n = 38 743)</td><td colspan="2">Comparison patients(n = 116 229)</td><td rowspan="3">P value</td></tr><tr><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td colspan="4"></td></tr><tr><td>1–15 840</td><td>10 066</td><td>25.98</td><td>22 550</td><td>19... |
50bd23c901edc0b8fd81316293b2c23af7de8a58d35413bd3b55c28f2315d700.png | complex | <table><tr><td></td><td></td><td colspan="3">cELISA</td></tr><tr><td></td><td></td><td>Positive</td><td>Negative</td><td>Total</td></tr><tr><td><i>T. equi</i> (A)</td><td></td><td></td><td></td><td></td></tr><tr><td rowspan="3"> IFAT</td><td>Positive</td><td>48</td><td>7</td><td>55</td></tr><tr><td>Negative</td><td>10<... | <table><tr><td></td><td></td><td colspan="3">cELISA</td></tr><tr><td></td><td></td><td>Positive</td><td>Negative</td><td>Total</td></tr><tr><td>T. equi (A)</td><td></td><td></td><td></td><td></td></tr></table> | <table><tr><td></td><td></td><td colspan="3">cELISA</td></tr><tr><td></td><td></td><td>Positive</td><td>Negative</td><td>Total</td></tr><tr><td rowspan="3">IFAT</td><td>Positive</td><td>48</td><td>7</td><td>55</td></tr><tr><td>Negative</td><td>10</td><td>43</td><td>53</td></tr><tr><td>Total</td><td>58</td><td>50</td><t... |
8e94baf0a4485346c4ad1e946fad0b18cf0ac4841eaa459a7c562485f327c76f.png | simple | <table><tr><td>Quality of life measure</td><td>BaselineN = 159</td><td>1-monthN = 136</td><td>4-monthsN = 127</td><td>p-value*</td></tr><tr><td>General health</td><td><i>77.3 </i>(<i>20.5</i>)</td><td><i>72.2 </i>(<i>23.7</i>)</td><td><i>72.0 </i>(<i>21.5</i>)</td><td>.<i>008</i></td></tr><tr><td> Spouse</td><td>74.0 (... | <table><tr><td>Quality of life measure</td><td>BaselineN = 159</td><td>1-monthN = 136</td><td>4-monthsN = 127</td><td>p-value*</td></tr><tr><td>General health</td><td>77.3 (20.5)</td><td>72.2 (23.7)</td><td>72.0 (21.5)</td><td>.008</td></tr><tr><td>Spouse</td><td>74.0 (19.8)</td><td>70.5 (19.8)</td><td>70.4 (22.0)</td>... | <table><tr><td>Quality of life measure</td><td>BaselineN = 159</td><td>1-monthN = 136</td><td>4-monthsN = 127</td><td>p-value*</td></tr><tr><td>Adult child</td><td>89.8 (16.9)</td><td>80.8 (24.6)</td><td>85.3 (19.1)</td><td>.261</td></tr><tr><td>Other relative</td><td>73.1 (28.3)</td><td>83.1 (19.7)</td><td>76.0 (24.0)... |
394454b38ee8f3bf293daf849f3e5c764cb297649d77621e7925dc3f34404e8c.png | simple | <table><tr><td></td><td>Aniso nucleosis (±)</td><td>Large cherry red nucleoli (±)</td><td>Small cherry red nucleoli (±)</td><td>Large cells (±)</td><td>Mesothelial like sheets (±)</td><td>3 dimensional cluster (±)</td></tr><tr><td>Malignant</td><td>7/4</td><td>9/2</td><td>2/9</td><td>4/7</... | <table><tr><td></td><td>Aniso nucleosis (±)</td><td>Large cherry red nucleoli (±)</td><td>Small cherry red nucleoli (±)</td><td>Large cells (±)</td><td>Mesothelial like sheets (±)</td><td>3 dimensional cluster (±)</td></tr><tr><td>Malignant</td><td>7/4</td><td>9/2</td><td>2/9</td><td>4/7</td><td>5/6</td><td>11/0</td></... | <table><tr><td></td><td>Aniso nucleosis (±)</td><td>Large cherry red nucleoli (±)</td><td>Small cherry red nucleoli (±)</td><td>Large cells (±)</td><td>Mesothelial like sheets (±)</td><td>3 dimensional cluster (±)</td></tr><tr><td>Non-malignant</td><td>17/26</td><td>1/42</td><td>20/23</td><td>39/4</td><td>21/22</td><td... |
83e30b3cbd5481e174e5c09e1f567d3a058cdb14345d75df605f98d79f2d20b3.png | simple | <table><tr><td>Variables</td><td>Disability Beta (SD)</td><td><i>T</i></td><td>Anxiety</td><td><i>t</i></td><td>Depression</td><td><i>t</i></td></tr><tr><td>Age</td><td>0.011 (0.016)</td><td>0.71</td><td>−0.046 (0.014)</td><td>−3.24 **</td><td>−0.014 (0.011)</td><td>−1.33</td></tr><tr><td>Organi... | <table><tr><td>Variables</td><td>Disability Beta (SD)</td><td>T</td><td>Anxiety</td><td>t</td><td>Depression</td><td>t</td></tr><tr><td>Ag</td><td>0.011 (0.016</td><td>0.7</td><td>−0.046 (</td><td>−3.24 *</td><td>−0.014 </td><td></td></tr></table> | <table><tr><td>e</td><td>)</td><td>1</td><td>0.014)</td><td>*</td><td>(0.011)</td><td>−1.33</td></tr><tr><td>Organic Beliefs</td><td>0.222 (0.052)</td><td>4.26 ***</td><td>0.035 (0.046)</td><td>0.76</td><td>0.071 (0.035)</td><td>2.01 *</td></tr><tr><td>Psychological Beliefs</td><td>0.229 (0.058)</td><td>3.94 ***</td><t... |
77c800c3cdbd22c9fe21948ec8410496d8b913a3d7d536f5ac2d01738231e35f.png | complex | <table><tr><td rowspan="2" colspan="2"></td><td colspan="2">No DGE</td><td colspan="2">DGE</td><td rowspan="2"><i>P</i></td></tr><tr><td colspan="2"><i>n</i> = 70</td><td colspan="2"><i>n</i> = 98</td></tr><tr><td colspan="2">Age, years</td><td colspan="2">62 (51–69)</td><td colspan="2">68 (60–74)</td><td><... | <table><tr><td rowspan="2" colspan="2"></td><td colspan="2">No DGE</td></tr><tr><td colspan="2">n = 70</td></tr><tr><td colspan="2">Age, years</td><td colspan="2">62 (51–69)</td></tr><tr><td colspan="4">Gender</td></tr><tr><td colspan="2">female</td><td>24</td><td>(34%)</td></tr><tr><td colspan="2">male</td><td>46</td>... | <table><tr><td colspan="2">DGE</td><td rowspan="2">P</td></tr><tr><td colspan="2">n = 98</td></tr><tr><td colspan="2">68 (60–74)</td><td>0.003</td></tr><tr><td colspan="2">Gender</td><td>0.39</td></tr><tr><td>40</td><td>(41%)</td><td></td></tr><tr><td>58</td><td>(59%)</td><td></td></tr><tr><td colspan="2">24,4 ± 4</td>... |
3e6e4c1a82d0a2f9a1c0ae4286aa0751246e0bef191f4e4e3f2ff06c8a9e3fd1.png | complex | <table><tr><td>Review</td><td>Professional background (code used in the quotes)</td><td>Knowledge of the clinical area</td><td>DTA-related knowledge</td><td>Systematic review methods</td><td>Academic role within university</td><td>Policy- making experience</td></tr><tr><td>Galactomannan detection for invasive aspergill... | <table><tr><td>Review</td><td>Professional background (code used in the quotes)</td><td>Knowledge of the clinical area</td><td>DTA-related knowledge</td><td>Systematic review methods</td><td>Academic role within university</td><td>Policy- making experience</td></tr><tr><td>Galactomannan detection for invasive aspergill... | <table><tr><td rowspan="2">ar lesions in patients presenting with stroke symptoms</td><td>wer (SR6)</td><td>Yes</td><td>ome</td><td>ood</td><td>s</td><td></td></tr><tr><td>Policy maker (PM4)</td><td>Yes</td><td>Good</td><td>Good</td><td>Yes</td><td>Yes</td></tr></table> |
8125576ce772c845e7510469679c7a056c0c8fddaad07490125e7c22cce7ea0f.png | simple | <table><tr><td>Variable</td><td>Cases (<i>n</i>=454)</td><td>Controls (<i>n</i>=512)</td><td><i>P</i></td></tr><tr><td>Age (years)</td><td>61.04 ± 10.81</td><td>61.05 ± 11.01</td><td>0.990</td></tr><tr><td>Female/male</td><td>167/287</td><td>180/332</td><td>0.599</td></tr><tr><td>Smoking (No/Yes)</td><td>184/... | <table><tr><td>Variable</td><td>Cases (n=454)</td></tr><tr><td>Age (years)</td><td>61.04 ± 10.81</td></tr><tr><td>Female/male</td><td>167/287</td></tr><tr><td>Smoking (No/Yes)</td><td>184/270</td></tr><tr><td>Drinking (No/Yes)</td><td>329/125</td></tr><tr><td>Diabetes (No/Yes)</td><td>295/159</td></tr><tr><td>FPG (mmol... | <table><tr><td>Controls (n=512)</td><td>P</td></tr><tr><td>61.05 ± 11.01</td><td>0.990</td></tr><tr><td>180/332</td><td>0.599</td></tr><tr><td>358/154</td><td><0.001</td></tr><tr><td>436/76</td><td><0.001</td></tr><tr><td>435/77</td><td><0.001</td></tr><tr><td>5.65 ± 1.46</td><td><0.001</td></tr><tr><td>300/212</td><td... |
f01beaaa82ed9a1a19c1d491d72d578fc43c58aefc43103daae448242da44eac.png | simple | <table><tr><td></td><td>$3000 single</td><td>12 mo. spacing</td><td>60 mo. spacing</td><td>$1000 single</td></tr><tr><td>$3000 single</td><td></td><td></td><td></td><td></td></tr><tr><td>12 mo. spacing</td><td><i>t</i> = −1.539, <i>p</i> = 0.14</td><td></td><td></td><td></td></tr><tr><td>60 mo. spacing</td><td><i... | <table><tr><td></td><td>$3000 single</td><td>12 mo. spacing</td><td>60 mo. spacing</td><td>$1000 single</td></tr><tr><td>$30</td><td></td><td></td><td></td><td></td></tr></table> | <table><tr><td>00 single</td><td></td><td></td><td></td></tr><tr><td>12 mo. spacing</td><td>t = −1.539, p = 0.14</td><td></td><td></td></tr><tr><td>60 mo. spacing</td><td>t = −1.31, p = 0.20</td><td>t = 0.77, p = 0.45</td><td></td></tr><tr><td>$1000 single</td><td>t = 0.87, p = 0.40</td><td>t = 1.67, p = 0.11</td><td>t... |
73b132560a2fdce13c776130a5d04070c81be19a725c6aaba84dbcaaf93fef80.png | complex | <table><tr><td>Question</td><td>Session</td><td><i>n</i></td><td>≥ 4 (%)</td></tr><tr><td rowspan="2">I believe the work in this session is relevant for professional nurses</td><td>1</td><td>52</td><td>98</td></tr><tr><td>2</td><td>49</td><td>84</td></tr><tr><td rowspan="2">I believe the work in this session is r... | <table><tr><td>Question</td><td>Session</td></tr><tr><td rowspan="2">I believe the work in this session is relevant for professional nurses</td><td>1</td></tr><tr><td>2</td></tr><tr><td rowspan="2">I believe the work in this session is relevant for me as an individual</td><td>1</td></tr><tr><td>2</td></tr><tr><td rowsp... | <table><tr><td>n</td><td>≥ 4 (%)</td></tr><tr><td>52</td><td>98</td></tr><tr><td>49</td><td>84</td></tr><tr><td>52</td><td>96</td></tr><tr><td>49</td><td>88</td></tr><tr><td>49</td><td>94</td></tr><tr><td>49</td><td>76</td></tr></table> |
6e85437b65f9bfbd00e89add70f07ecb2ca72cc496feaa14d0ec12a202d62a30.png | simple | <table><tr><td>Algorithms</td><td>MAPE (%)</td><td>RMSPE (%)</td><td>Error of RUL prediction</td></tr><tr><td>INW–ESN (dynamica)</td><td>9.32</td><td>7.27</td><td>23 min</td></tr><tr><td>INW–ESN (static)</td><td>17.14</td><td>14.64</td><td>Failed</td></tr><tr><td>RNN (dynamica)</td><td>16.38</td><td>13.44</... | <table><tr><td>Algorithms</td><td>MAPE (%)</td><td>RMSPE (%)</td><td>Error of RUL prediction</td></tr><tr><td>INW–ESN (dynamica)</td><td>9.32</td><td>7.27</td><td>23 min</td></tr></table> | <table><tr><td>Algorithms</td><td>MAPE (%)</td><td>RMSPE (%)</td><td>Error of RUL prediction</td></tr><tr><td>INW–ESN (static)</td><td>17.14</td><td>14.64</td><td>Failed</td></tr><tr><td>RNN (dynamica)</td><td>16.38</td><td>13.44</td><td>138 min</td></tr><tr><td>ESN (dynamica)</td><td>14.60</td><td>10.87</td><td>161 mi... |
dbf7baa0040eea10ce213b1d465680305ef711ee92ff17dfd6427791ad7c8227.png | complex | <table><tr><td>PCR</td><td>Forward (F) primer/reverse (R) primer (5′–3′)</td><td>PCR mixture</td><td>Cycling conditions</td></tr><tr><td rowspan="7">rDNA21</td><td>Nest1 F: GCTGTAGGTGAACCTGCAGCAGCTGGATCATT</td><td rowspan="7">50 μL reaction; 5 μL DNA from filter papers (or 5 μL N1), 25 ... | <table><tr><td>PCR</td><td>Forward (F) primer/reverse (R) primer (5′–3′)</td><td>PCR mixture</td><td>Cycling conditions</td></tr><tr><td rowspan="6">rDNA21</td><td>Nest1 F: GCTGTAGGTGAACCTGCAGCAGCTGGATCATT</td><td rowspan="6">50 μL reaction; 5 μL DNA from filter papers (or 5 μL N1), 25 μL QIAGEN HotStar Taq Master Mix ... | <table><tr><td>rDNA21</td><td></td><td>50 μL reaction; 5 μL DNA from filter papers (or 5 μL N1), 25 μL QIAGEN HotStar Taq Master Mix (QIAGEN), 0.3 μM primers</td><td>75°C, 10 minutes</td></tr><tr><td rowspan="6">ITS222</td><td>F: GGGAGAAGCTCTATTGTG</td><td rowspan="6">25 μL reaction; 1 μL N2 product from rDNA PCR, KCl ... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.